Extracellular Vesicles, Stem Cells and the Role of miRNAs in Neurodegeneration

Wang, Y.; Ji, X.; Leak, R.K.; Chen, F.; Cao, G. Stem cell therapies in age-related neurodegenerative diseases and stroke. Ageing Res. Rev., 2017, 34, 39-50.
[http://dx.doi.org/10.1016/j.arr.2016.11.002] [PMID: 27876573]

Lee, R.H.; Pulin, A.A.; Seo, M.J.; Kota, D.J.; Ylostalo, J.; Larson, B.L.; Semprun-Prieto, L.; Delafontaine, P.; Prockop, D.J. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell, 2009, 5(1), 54-63.
[http://dx.doi.org/10.1016/j.stem.2009.05.003] [PMID: 19570514]

Iso, Y.; Spees, J.L.; Serrano, C.; Bakondi, B.; Pochampally, R.; Song, Y.H.; Sobel, B.E.; Delafontaine, P.; Prockop, D.J. Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem. Biophys. Res. Commun., 2007, 354(3), 700-706.
[http://dx.doi.org/10.1016/j.bbrc.2007.01.045] [PMID: 17257581]

Gao, J.; Dennis, J.E.; Muzic, R.F.; Lundberg, M.; Caplan, A.I. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs, 2001, 169(1), 12-20.
[http://dx.doi.org/10.1159/000047856] [PMID: 11340257]

Bruno, S.; Chiabotto, G.; Favaro, E.; Deregibus, M.C.; Camussi, G. Role of extracellular vesicles in stem cell biology. Am. J. Physiol. Cell Physiol., 2019, 317(2), C303-C313.
[http://dx.doi.org/10.1152/ajpcell.00129.2019] [PMID: 31091143]

Lai, R.C.; Arslan, F.; Lee, M.M.; Sze, N.S.; Choo, A.; Chen, T.S.; Salto-Tellez, M.; Timmers, L.; Lee, C.N.; El Oakley, R.M.; Pasterkamp, G.; de Kleijn, D.P.; Lim, S.K. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. (Amst.), 2010, 4(3), 214-222.
[http://dx.doi.org/10.1016/j.scr.2009.12.003] [PMID: 20138817]

Bruno, S.; Grange, C.; Deregibus, M.C.; Calogero, R.A.; Saviozzi, S.; Collino, F.; Morando, L.; Busca, A.; Falda, M.; Bussolati, B.; Tetta, C.; Camussi, G. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J. Am. Soc. Nephrol., 2009, 20(5), 1053-1067.
[http://dx.doi.org/10.1681/ASN.2008070798] [PMID: 19389847]

van Niel, G.; D’Angelo, G.; Raposo, G. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol., 2018, 19(4), 213-228.
[http://dx.doi.org/10.1038/nrm.2017.125] [PMID: 29339798]

Skog, J.; Würdinger, T.; van Rijn, S.; Meijer, D.H.; Gainche, L.; Sena-Esteves, M.; Curry, W.T., Jr; Carter, B.S.; Krichevsky, A.M.; Breake-field, X.O. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol., 2008, 10(12), 1470-1476.
[http://dx.doi.org/10.1038/ncb1800] [PMID: 19011622]

Lai, C.P.; Kim, E.Y.; Badr, C.E.; Weissleder, R.; Mempel, T.R.; Tannous, B.A.; Breakefield, X.O. Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters. Nat. Commun., 2015, 6, 7029.
[http://dx.doi.org/10.1038/ncomms8029] [PMID: 25967391]

Ratajczak, J.; Miekus, K.; Kucia, M.; Zhang, J.; Reca, R.; Dvorak, P.; Ratajczak, M.Z. Embryonic stem cell-derived microvesicles repro-gram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia, 2006, 20(5), 847-856.
[http://dx.doi.org/10.1038/sj.leu.2404132] [PMID: 16453000]

Valadi, H.; Ekström, K.; Bossios, A.; Sjöstrand, M.; Lee, J.J.; Lötvall, J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol., 2007, 9(6), 654-659.
[http://dx.doi.org/10.1038/ncb1596] [PMID: 17486113]

Zhuang, X.; Xiang, X.; Grizzle, W.; Sun, D.; Zhang, S.; Axtell, R.C.; Ju, S.; Mu, J.; Zhang, L.; Steinman, L.; Miller, D.; Zhang, H.G. Treat-ment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol. Ther., 2011, 19(10), 1769-1779.
[http://dx.doi.org/10.1038/mt.2011.164] [PMID: 21915101]

Uccelli, A.; Moretta, L.; Pistoia, V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol., 2008, 8(9), 726-736.
[http://dx.doi.org/10.1038/nri2395] [PMID: 19172693]

Romanov, Y.A.; Svintsitskaya, V.A.; Smirnov, V.N. Searching for alternative sources of postnatal human mesenchymal stem cells: candi-date MSC-like cells from umbilical cord. Stem Cells, 2003, 21(1), 105-110.
[http://dx.doi.org/10.1634/stemcells.21-1-105] [PMID: 12529557]

Zuk, P.A.; Zhu, M.; Ashjian, P.; De Ugarte, D.A.; Huang, J.I.; Mizuno, H.; Alfonso, Z.C.; Fraser, J.K.; Benhaim, P.; Hedrick, M.H. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell, 2002, 13(12), 4279-4295.
[http://dx.doi.org/10.1091/mbc.e02-02-0105] [PMID: 12475952]

In ’t Anker, P.S.; Scherjon, S.A.; Kleijburg-van der Keur, C.; Noort, W.A.; Claas, F.H.; Willemze, R.; Fibbe, W.E.; Kanhai, H.H. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood, 2003, 102(4), 1548-1549.
[http://dx.doi.org/10.1182/blood-2003-04-1291] [PMID: 12900350]

Fukuchi, Y.; Nakajima, H.; Sugiyama, D.; Hirose, I.; Kitamura, T.; Tsuji, K. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells, 2004, 22(5), 649-658.
[http://dx.doi.org/10.1634/stemcells.22-5-649] [PMID: 15342929]

Boyle, A.J.; McNiece, I.K.; Hare, J.M. Mesenchymal stem cell therapy for cardiac repair. Methods Mol. Biol., 2010, 660, 65-84.
[http://dx.doi.org/10.1007/978-1-60761-705-1_5] [PMID: 20680813]

Bhandari, D.R.; Seo, K.W.; Sun, B.; Seo, M.S.; Kim, H.S.; Seo, Y.J.; Marcin, J.; Forraz, N.; Roy, H.L.; Larry, D.; Colin, M.; Kang, K.S. The simplest method for in vitro β-cell production from human adult stem cells. Differentiation, 2011, 82(3), 144-152.
[http://dx.doi.org/10.1016/j.diff.2011.06.003] [PMID: 21782317]

Banas, A.; Teratani, T.; Yamamoto, Y.; Tokuhara, M.; Takeshita, F.; Quinn, G.; Okochi, H.; Ochiya, T. Adipose tissue-derived mesen-chymal stem cells as a source of human hepatocytes. Hepatology, 2007, 46(1), 219-228.
[http://dx.doi.org/10.1002/hep.21704] [PMID: 17596885]

Pournasr, B.; Mohamadnejad, M.; Bagheri, M.; Aghdami, N.; Shahsavani, M.; Malekzadeh, R.; Baharvand, H. In vitro differentiation of human bone marrow mesenchymal stem cells into hepatocyte-like cells. Arch. Iran Med., 2011, 14(4), 244-249.
[PMID: 21726099]

Yin, L.; Zhu, Y.; Yang, J.; Ni, Y.; Zhou, Z.; Chen, Y.; Wen, L. Adipose tissue-derived mesenchymal stem cells differentiated into hepato-cyte-like cells in vivo and in vitro. Mol. Med. Rep., 2015, 11(3), 1722-1732.
[http://dx.doi.org/10.3892/mmr.2014.2935] [PMID: 25395242]

Ferrari, G.; Cusella-De Angelis, G.; Coletta, M.; Paolucci, E.; Stornaiuolo, A.; Cossu, G.; Mavilio, F. Muscle regeneration by bone marrow-derived myogenic progenitors. Science, 1998, 279(5356), 1528-1530.
[http://dx.doi.org/10.1126/science.279.5356.1528] [PMID: 9488650]

Planat-Bénard, V.; Menard, C.; André, M.; Puceat, M.; Perez, A.; Garcia-Verdugo, J.M.; Pénicaud, L.; Casteilla, L. Spontaneous cardiomy-ocyte differentiation from adipose tissue stroma cells. Circ. Res., 2004, 94(2), 223-229.
[http://dx.doi.org/10.1161/01.RES.0000109792.43271.47] [PMID: 14656930]

Rodríguez, L.V.; Alfonso, Z.; Zhang, R.; Leung, J.; Wu, B.; Ignarro, L.J. Clonogenic multipotent stem cells in human adipose tissue differ-entiate into functional smooth muscle cells. Proc. Natl. Acad. Sci. USA, 2006, 103(32), 12167-12172.
[http://dx.doi.org/10.1073/pnas.0604850103] [PMID: 16880387]

Sanchez-Ramos, J.; Song, S.; Cardozo-Pelaez, F.; Hazzi, C.; Stedeford, T.; Willing, A.; Freeman, T.B.; Saporta, S.; Janssen, W.; Patel, N.; Cooper, D.R.; Sanberg, P.R. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp. Neurol., 2000, 164(2), 247-256.
[http://dx.doi.org/10.1006/exnr.2000.7389] [PMID: 10915564]

Wosnitza, M.; Hemmrich, K.; Groger, A.; Gräber, S.; Pallua, N. Plasticity of human adipose stem cells to perform adipogenic and endothe-lial differentiation. Differentiation, 2007, 75(1), 12-23.
[http://dx.doi.org/10.1111/j.1432-0436.2006.00110.x] [PMID: 17244018]

Majumdar, M.K.; Thiede, M.A.; Haynesworth, S.E.; Bruder, S.P.; Gerson, S.L. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J. Hematother. Stem Cell Res., 2000, 9(6), 841-848.
[http://dx.doi.org/10.1089/152581600750062264] [PMID: 11177595]

Bifari, F.; Lisi, V.; Mimiola, E.; Pasini, A.; Krampera, M. Immune modulation by mesenchymal stem cells. Transfus. Med. Hemother., 2008, 35(3), 194-204.
[http://dx.doi.org/10.1159/000128968] [PMID: 21547117]

Forbes, G.M.; Sturm, M.J.; Leong, R.W.; Sparrow, M.P.; Segarajasingam, D.; Cummins, A.G.; Phillips, M.; Herrmann, R.P. A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn’s disease refractory to biologic therapy. Clin. Gastroenterol. Hepatol., 2014, 12(1), 64-71.
[http://dx.doi.org/10.1016/j.cgh.2013.06.021] [PMID: 23872668]

González, M.A.; Gonzalez-Rey, E.; Rico, L.; Büscher, D.; Delgado, M. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology, 2009, 136(3), 978-989.
[http://dx.doi.org/10.1053/j.gastro.2008.11.041] [PMID: 19135996]

Le Blanc, K.; Tammik, C.; Rosendahl, K.; Zetterberg, E.; Ringdén, O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol., 2003, 31(10), 890-896.
[http://dx.doi.org/10.1016/S0301-472X(03)00110-3] [PMID: 14550804]

Aggarwal, S.; Pittenger, M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 2005, 105(4), 1815-1822.
[http://dx.doi.org/10.1182/blood-2004-04-1559] [PMID: 15494428]

Corcione, A.; Benvenuto, F.; Ferretti, E.; Giunti, D.; Cappiello, V.; Cazzanti, F.; Risso, M.; Gualandi, F.; Mancardi, G.L.; Pistoia, V.; Uccel-li, A. Human mesenchymal stem cells modulate B-cell functions. Blood, 2006, 107(1), 367-372.
[http://dx.doi.org/10.1182/blood-2005-07-2657] [PMID: 16141348]

Jiang, X.X.; Zhang, Y.; Liu, B.; Zhang, S.X.; Wu, Y.; Yu, X.D.; Mao, N. Human mesenchymal stem cells inhibit differentiation and func-tion of monocyte-derived dendritic cells. Blood, 2005, 105(10), 4120-4126.
[http://dx.doi.org/10.1182/blood-2004-02-0586] [PMID: 15692068]

Nauta, A.J.; Fibbe, W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood, 2007, 110(10), 3499-3506.
[http://dx.doi.org/10.1182/blood-2007-02-069716] [PMID: 17664353]

Shi, M.; Liu, Z.W.; Wang, F.S. Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin. Exp. Immunol., 2011, 164(1), 1-8.
[http://dx.doi.org/10.1111/j.1365-2249.2011.04327.x] [PMID: 21352202]

Chapel, A.; Bertho, J.M.; Bensidhoum, M.; Fouillard, L.; Young, R.G.; Frick, J.; Demarquay, C.; Cuvelier, F.; Mathieu, E.; Trompier, F.; Dudoignon, N.; Germain, C.; Mazurier, C.; Aigueperse, J.; Borneman, J.; Gorin, N.C.; Gourmelon, P.; Thierry, D. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J. Gene Med., 2003, 5(12), 1028-1038.
[http://dx.doi.org/10.1002/jgm.452] [PMID: 14661178]

Fong, E.L.; Chan, C.K.; Goodman, S.B. Stem cell homing in musculoskeletal injury. Biomaterials, 2011, 32(2), 395-409.
[http://dx.doi.org/10.1016/j.biomaterials.2010.08.101] [PMID: 20933277]

Mouiseddine, M.; François, S.; Semont, A.; Sache, A.; Allenet, B.; Mathieu, N.; Frick, J.; Thierry, D.; Chapel, A. Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model. Br. J. Radiol., 2007, 80(Spec No 1), S49-S55.
[http://dx.doi.org/10.1259/bjr/25927054] [PMID: 17704326]

Kidd, S.; Spaeth, E.; Dembinski, J.L.; Dietrich, M.; Watson, K.; Klopp, A.; Battula, V.L.; Weil, M.; Andreeff, M.; Marini, F.C. Direct evi-dence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells, 2009, 27(10), 2614-2623.
[http://dx.doi.org/10.1002/stem.187] [PMID: 19650040]

Galland, S.; Stamenkovic, I. Mesenchymal stromal cells in cancer: a review of their immunomodulatory functions and dual effects on tumor progression. J. Pathol., 2020, 250(5), 555-572.
[http://dx.doi.org/10.1002/path.5357] [PMID: 31608444]

Kirchner, B.; Buschmann, D.; Paul, V.; Pfaffl, M.W. Postprandial transfer of colostral extracellular vesicles and their protein and miRNA cargo in neonatal calves. PLoS One, 2020, 15(2), e0229606.
[http://dx.doi.org/10.1371/journal.pone.0229606] [PMID: 32109241]

Cufaro, M.C.; Pieragostino, D.; Lanuti, P.; Rossi, C.; Cicalini, I.; Federici, L.; De Laurenzi, V.; Del Boccio, P. Extracellular vesicles and their potential use in monitoring cancer progression and therapy: The contribution of proteomics. J. Oncol., 2019, 2019, 1639854.
[http://dx.doi.org/10.1155/2019/1639854] [PMID: 31281356]

Théry, C.; Witwer, K.W.; Aikawa, E.; Alcaraz, M.J.; Anderson, J.D.; Andriantsitohaina, R.; Antoniou, A.; Arab, T.; Archer, F.; Atkin-Smith, G.K.; Ayre, D.C.; Bach, J.M.; Bachurski, D.; Baharvand, H.; Balaj, L.; Baldacchino, S.; Bauer, N.N.; Baxter, A.A.; Bebawy, M.; Beckham, C.; Bedina Zavec, A.; Benmoussa, A.; Berardi, A.C.; Bergese, P.; Bielska, E.; Blenkiron, C.; Bobis-Wozowicz, S.; Boilard, E.; Boireau, W.; Bongiovanni, A.; Borràs, F.E.; Bosch, S.; Boulanger, C.M.; Breakefield, X.; Breglio, A.M.; Brennan, M.A.; Brigstock, D.R.; Brisson, A.; Broekman, M.L.; Bromberg, J.F.; Bryl-Górecka, P.; Buch, S.; Buck, A.H.; Burger, D.; Busatto, S.; Buschmann, D.; Bussolati, B.; Buzás, E.I.; Byrd, J.B.; Camussi, G.; Carter, D.R.; Caruso, S.; Chamley, L.W.; Chang, Y.T.; Chen, C.; Chen, S.; Cheng, L.; Chin, A.R.; Clayton, A.; Clerici, S.P.; Cocks, A.; Cocucci, E.; Coffey, R.J.; Cordeiro-da-Silva, A.; Couch, Y.; Coumans, F.A.; Coyle, B.; Crescitelli, R.; Criado, M.F.; D’Souza-Schorey, C.; Das, S.; Datta Chaudhuri, A.; de Candia, P.; De Santana, E.F.; De Wever, O.; Del Portillo, H.A.; De-maret, T.; Deville, S.; Devitt, A.; Dhondt, B.; Di Vizio, D.; Dieterich, L.C.; Dolo, V.; Dominguez Rubio, A.P.; Dominici, M.; Dourado, M.R.; Driedonks, T.A.; Duarte, F.V.; Duncan, H.M.; Eichenberger, R.M.; Ekström, K.; El Andaloussi, S.; Elie-Caille, C.; Erdbrügger, U.; Falcón-Pérez, J.M.; Fatima, F.; Fish, J.E.; Flores-Bellver, M.; Försönits, A.; Frelet-Barrand, A.; Fricke, F.; Fuhrmann, G.; Gabrielsson, S.; Gámez-Valero, A.; Gardiner, C.; Gärtner, K.; Gaudin, R.; Gho, Y.S.; Giebel, B.; Gilbert, C.; Gimona, M.; Giusti, I.; Goberdhan, D.C.; Görgens, A.; Gorski, S.M.; Greening, D.W.; Gross, J.C.; Gualerzi, A.; Gupta, G.N.; Gustafson, D.; Handberg, A.; Haraszti, R.A.; Harrison, P.; Hegyesi, H.; Hendrix, A.; Hill, A.F.; Hochberg, F.H.; Hoffmann, K.F.; Holder, B.; Holthofer, H.; Hosseinkhani, B.; Hu, G.; Huang, Y.; Huber, V.; Hunt, S.; Ibrahim, A.G.; Ikezu, T.; Inal, J.M.; Isin, M.; Ivanova, A.; Jackson, H.K.; Jacobsen, S.; Jay, S.M.; Jayachandran, M.; Jenster, G.; Jiang, L.; Johnson, S.M.; Jones, J.C.; Jong, A.; Jovanovic-Talisman, T.; Jung, S.; Kalluri, R.; Kano, S.I.; Kaur, S.; Kawamura, Y.; Keller, E.T.; Khamari, D.; Khomyakova, E.; Khvorova, A.; Kierulf, P.; Kim, K.P.; Kislinger, T.; Klingeborn, M.; Klinke, D.J., II; Kornek, M. Kosanović M.M.; Kovács, A.F.; Krämer-Albers, E.M.; Krasemann, S.; Krause, M.; Kurochkin, I.V.; Kusuma, G.D.; Kuypers, S.; Laitinen, S.; Langevin, S.M.; Languino, L.R.; Lannigan, J.; Lässer, C.; Laurent, L.C.; Lavieu, G.; Lázaro-Ibáñez, E.; Le Lay, S.; Lee, M.S.; Lee, Y.X.F.; Lemos, D.S.; Lenassi, M.; Leszczynska, A.; Li, I.T.; Liao, K.; Libregts, S.F.; Ligeti, E.; Lim, R.; Lim, S.K.; Linē A.; Linnemannstöns, K.; Llorente, A.; Lombard, C.A.; Lorenowicz, M.J.; Lörincz, A.M.; Lötvall, J.; Lovett, J.; Lowry, M.C.; Loyer, X.; Lu, Q.; Lukomska, B.; Lunavat, T.R.; Maas, S.L.; Malhi, H.; Marcilla, A.; Mariani, J.; Mariscal, J.; Martens-Uzunova, E.S.; Martin-Jaular, L.; Martinez, M.C.; Martins, V.R.; Mathieu, M.; Mathivanan, S.; Maugeri, M.; McGinnis, L.K.; McVey, M.J.; Meckes, D.G., Jr; Meehan, K.L.; Mertens, I.; Minciacchi, V.R.; Möller, A.; Møller Jørgensen, M.; Morales-Kastresana, A.; Morhayim, J.; Mullier, F.; Mura-ca, M.; Musante, L.; Mussack, V.; Muth, D.C.; Myburgh, K.H.; Najrana, T.; Nawaz, M.; Nazarenko, I.; Nejsum, P.; Neri, C.; Neri, T.; Nieuwland, R.; Nimrichter, L.; Nolan, J.P.; Nolte-’t Hoen, E.N.; Noren Hooten, N.; O’Driscoll, L.; O’Grady, T.; O’Loghlen, A.; Ochiya, T.; Olivier, M.; Ortiz, A.; Ortiz, L.A.; Osteikoetxea, X.; Østergaard, O.; Ostrowski, M.; Park, J.; Pegtel, D.M.; Peinado, H.; Perut, F.; Pfaffl, M.W.; Phinney, D.G.; Pieters, B.C.; Pink, R.C.; Pisetsky, D.S.; Pogge von Strandmann, E.; Polakovicova, I.; Poon, I.K.; Powell, B.H.; Pra-da, I.; Pulliam, L.; Quesenberry, P.; Radeghieri, A.; Raffai, R.L.; Raimondo, S.; Rak, J.; Ramirez, M.I.; Raposo, G.; Rayyan, M.S.; Regev-Rudzki, N.; Ricklefs, F.L.; Robbins, P.D.; Roberts, D.D.; Rodrigues, S.C.; Rohde, E.; Rome, S.; Rouschop, K.M.; Rughetti, A.; Russell, A.E.; Saá, P.; Sahoo, S.; Salas-Huenuleo, E.; Sánchez, C.; Saugstad, J.A.; Saul, M.J.; Schiffelers, R.M.; Schneider, R.; Schøyen, T.H.; Scott, A.; Shahaj, E.; Sharma, S.; Shatnyeva, O.; Shekari, F.; Shelke, G.V.; Shetty, A.K.; Shiba, K.; Siljander, P.R.; Silva, A.M.; Skowronek, A.; Snyder, O.L., II; Soares, R.P.; Sódar, B.W.; Soekmadji, C.; Sotillo, J.; Stahl, P.D.; Stoorvogel, W.; Stott, S.L.; Strasser, E.F.; Swift, S.; Taha-ra, H.; Tewari, M.; Timms, K.; Tiwari, S.; Tixeira, R.; Tkach, M.; Toh, W.S.; Tomasini, R.; Torrecilhas, A.C.; Tosar, J.P.; Toxavidis, V.; Urbanelli, L.; Vader, P.; van Balkom, B.W.; van der Grein, S.G.; Van Deun, J.; van Herwijnen, M.J.; Van Keuren-Jensen, K.; van Niel, G.; van Royen, M.E.; van Wijnen, A.J.; Vasconcelos, M.H.; Vechetti, I.J., Jr; Veit, T.D.; Vella, L.J.; Velot, É.; Verweij, F.J.; Vestad, B.; Viñas, J.L.; Visnovitz, T.; Vukman, K.V.; Wahlgren, J.; Watson, D.C.; Wauben, M.H.; Weaver, A.; Webber, J.P.; Weber, V.; Wehman, A.M.; Weiss, D.J.; Welsh, J.A.; Wendt, S.; Wheelock, A.M.; Wiener, Z.; Witte, L.; Wolfram, J.; Xagorari, A.; Xander, P.; Xu, J.; Yan, X.; Yáñez-Mó, M.; Yin, H.; Yuana, Y.; Zappulli, V.; Zarubova, J.; Žėkas, V.; Zhang, J.Y.; Zhao, Z.; Zheng, L.; Zheutlin, A.R.; Zickler, A.M.; Zim-mermann, P.; Zivkovic, A.M.; Zocco, D.; Zuba-Surma, E.K. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles, 2018, 7(1), 1535750.
[http://dx.doi.org/10.1080/20013078.2018.1535750] [PMID: 30637094]

Latifkar, A.; Hur, Y.H.; Sanchez, J.C.; Cerione, R.A.; Antonyak, M.A. New insights into extracellular vesicle biogenesis and function. J. Cell Sci., 2019, 132(13), 132.
[http://dx.doi.org/10.1242/jcs.222406] [PMID: 31263077]

Gézsi, A.; Kovács, Á.; Visnovitz, T.; Buzás, E.I. Systems biology approaches to investigating the roles of extracellular vesicles in human diseases. Exp. Mol. Med., 2019, 51(3), 1-11.
[http://dx.doi.org/10.1038/s12276-019-0226-2] [PMID: 30872567]

Tang, T.T.; Lv, L.L.; Lan, H.Y.; Liu, B.C. Extracellular vesicles: Opportunities and challenges for the treatment of renal diseases. Front. Physiol., 2019, 10, 226.
[http://dx.doi.org/10.3389/fphys.2019.00226] [PMID: 30941051]

Kishore, R.; Khan, M. More than tiny sacks: Stem cell exosomes as cell-free modality for cardiac repair. Circ. Res., 2016, 118(2), 330-343.
[http://dx.doi.org/10.1161/CIRCRESAHA.115.307654] [PMID: 26838317]

Bebelman, M.P.; Smit, M.J.; Pegtel, D.M.; Baglio, S.R. Biogenesis and function of extracellular vesicles in cancer. Pharmacol. Ther., 2018, 188, 1-11.
[http://dx.doi.org/10.1016/j.pharmthera.2018.02.013] [PMID: 29476772]

Tricarico, C.; Clancy, J.; D’Souza-Schorey, C. Biology and biogenesis of shed microvesicles. Small GTPases, 2017, 8(4), 220-232.
[http://dx.doi.org/10.1080/21541248.2016.1215283] [PMID: 27494381]

Kalra, H.; Simpson, R.J.; Ji, H.; Aikawa, E.; Altevogt, P.; Askenase, P.; Bond, V.C.; Borràs, F.E.; Breakefield, X.; Budnik, V.; Buzas, E.; Camussi, G.; Clayton, A.; Cocucci, E.; Falcon-Perez, J.M.; Gabrielsson, S.; Gho, Y.S.; Gupta, D.; Harsha, H.C.; Hendrix, A.; Hill, A.F.; In-al, J.M.; Jenster, G.; Krämer-Albers, E.M.; Lim, S.K.; Llorente, A.; Lötvall, J.; Marcilla, A.; Mincheva-Nilsson, L.; Nazarenko, I.; Nieu-wland, R.; Nolte-’t Hoen, E.N.; Pandey, A.; Patel, T.; Piper, M.G.; Pluchino, S.; Prasad, T.S.; Rajendran, L.; Raposo, G.; Record, M.; Reid, G.E.; Sánchez-Madrid, F.; Schiffelers, R.M.; Siljander, P.; Stensballe, A.; Stoorvogel, W.; Taylor, D.; Thery, C.; Valadi, H.; van Balkom, B.W.; Vázquez, J.; Vidal, M.; Wauben, M.H.; Yáñez-Mó, M.; Zoeller, M.; Mathivanan, S. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol., 2012, 10(12), e1001450.
[http://dx.doi.org/10.1371/journal.pbio.1001450] [PMID: 23271954]

EL Andaloussi, S.; Mäger, I.; Breakefield, X.O.; Wood, M.J. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat. Rev. Drug Discov., 2013, 12(5), 347-357.
[http://dx.doi.org/10.1038/nrd3978] [PMID: 23584393]

Borges, F.T.; Reis, L.A.; Schor, N. Extracellular vesicles: structure, function, and potential clinical uses in renal diseases. Braz. J. Med. Biol. Res., 2013, 46(10), 824-830.
[http://dx.doi.org/10.1590/1414-431X20132964] [PMID: 24141609]

Bayraktar, R.; Van Roosbroeck, K.; Calin, G.A. Cell-to-cell communication: microRNAs as hormones. Mol. Oncol., 2017, 11(12), 1673-1686.
[http://dx.doi.org/10.1002/1878-0261.12144] [PMID: 29024380]

Ihara, T.; Yamamoto, T.; Sugamata, M.; Okumura, H.; Ueno, Y. The process of ultrastructural changes from nuclei to apoptotic body. Virchows Arch., 1998, 433(5), 443-447.
[http://dx.doi.org/10.1007/s004280050272] [PMID: 9849859]

Doyle, L.M.; Wang, M.Z. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells, 2019, 8(7), 8.
[http://dx.doi.org/10.3390/cells8070727] [PMID: 31311206]

Mettinger, K.L.; Rameshwar, P.; Kumar, V. Exosomes, Stem Cells and MicroRNA. In: Aging, Cancer Age Related Disorders, Springer. 2018, 9(8), 968.

Temoche-Diaz, M.M.; Shurtleff, M.J.; Nottingham, R.M.; Yao, J.; Fadadu, R.P.; Lambowitz, A.M.; Schekman, R. Distinct mechanisms of microRNA sorting into cancer cell-derived extracellular vesicle subtypes. eLife, 2019, 8, 8.
[http://dx.doi.org/10.7554/eLife.47544] [PMID: 31436530]

Pfeifer, P.; Werner, N.; Jansen, F. Role and function of microRNAs in extracellular vesicles in cardiovascular biology. BioMed Res. Int., 2015, 2015, 161393.
[http://dx.doi.org/10.1155/2015/161393] [PMID: 26558258]

Denk, J.; Boelmans, K.; Siegismund, C.; Lassner, D.; Arlt, S.; Jahn, H. MicroRNA profiling of CSF reveals potential biomarkers to detect Alzheimer’s disease. PLoS One, 2015, 10(5), e0126423.
[http://dx.doi.org/10.1371/journal.pone.0126423] [PMID: 25992776]

Ceafalan, L.C.; Ioghen, O.C.; Marta, D.S.; Constantin, A.; Alexandru, N.; Nemecz, M.; Tanko, G.; Filippi, A.; Magda, S.L.; Bojin, F.; Paunescu, V.; Vinereanu, D.; Georgescu, A.; Gherghiceanu, M. Part two: Extracellular vesicles as a risk factor in neurodegenerative dis-eases; IntechOpen, 2019.

Ciregia, F.; Urbani, A.; Palmisano, G. Extracellular Vesicles in Brain Tumors and Neurodegenerative Diseases. Front. Mol. Neurosci., 2017, 10, 276.
[http://dx.doi.org/10.3389/fnmol.2017.00276] [PMID: 28912682]

Caruso Bavisotto, C.; Scalia, F.; Marino Gammazza, A.; Carlisi, D.; Bucchieri, F.; Conway de Macario, E.; Macario, A.J.L.; Cappello, F.; Campanella, C. Extracellular Vesicle-Mediated Cell(-) Cell Communication in the Nervous System: Focus on Neurological Diseases. Int. J. Mol. Sci., 2019, 20(2), 434.
[http://dx.doi.org/10.3390/ijms20020434]

Peters, A.; Fairén, A. Smooth and sparsely-spined stellate cells in the visual cortex of the rat: a study using a combined Golgi-electron microscopic technique. J. Comp. Neurol., 1978, 181(1), 129-171.
[http://dx.doi.org/10.1002/cne.901810108] [PMID: 681555]

Blackburn, D.; Sargsyan, S.; Monk, P.N.; Shaw, P.J. Astrocyte function and role in motor neuron disease: a future therapeutic target? Glia, 2009, 57(12), 1251-1264.
[http://dx.doi.org/10.1002/glia.20848] [PMID: 19373940]

Sidoryk-Wegrzynowicz, M.; Wegrzynowicz, M.; Lee, E.; Bowman, A.B.; Aschner, M. Role of astrocytes in brain function and disease. Toxicol. Pathol., 2011, 39(1), 115-123.
[http://dx.doi.org/10.1177/0192623310385254] [PMID: 21075920]

Sofroniew, M.V. Astrocyte barriers to neurotoxic inflammation. Nat. Rev. Neurosci., 2015, 16(5), 249-263.
[http://dx.doi.org/10.1038/nrn3898] [PMID: 25891508]

Agnati, L.F.; Guidolin, D.; Maura, G.; Marcoli, M.; Leo, G.; Carone, C.; De Caro, R.; Genedani, S.; Borroto-Escuela, D.O.; Fuxe, K. Infor-mation handling by the brain: proposal of a new “paradigm” involving the roamer type of volume transmission and the tunneling nanotube type of wiring transmission. J. Neural Transm. (Vienna), 2014, 121(12), 1431-1449.
[http://dx.doi.org/10.1007/s00702-014-1240-0] [PMID: 24866694]

Guescini, M.; Genedani, S.; Stocchi, V.; Agnati, L.F. Astrocytes and Glioblastoma cells release exosomes carrying mtDNA. J. Neural Transm. (Vienna), 2010, 117(1), 1-4.
[http://dx.doi.org/10.1007/s00702-009-0288-8] [PMID: 19680595]

Pascua-Maestro, R.; González, E.; Lillo, C.; Ganfornina, M.D.; Falcón-Pérez, J.M.; Sanchez, D. Extracellular vesicles secreted by astroglial cells transport apolipoprotein D to neurons and mediate neuronal survival upon oxidative stress. Front. Cell. Neurosci., 2019, 12, 526.
[http://dx.doi.org/10.3389/fncel.2018.00526] [PMID: 30687015]

Taylor, A.R.; Robinson, M.B.; Gifondorwa, D.J.; Tytell, M.; Milligan, C.E. Regulation of heat shock protein 70 release in astrocytes: role of signaling kinases. Dev. Neurobiol., 2007, 67(13), 1815-1829.
[http://dx.doi.org/10.1002/dneu.20559] [PMID: 17701989]

Wang, G.; Dinkins, M.; He, Q.; Zhu, G.; Poirier, C.; Campbell, A.; Mayer-Proschel, M.; Bieberich, E. Astrocytes secrete exosomes en-riched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD). J. Biol. Chem., 2012, 287(25), 21384-21395.
[http://dx.doi.org/10.1074/jbc.M112.340513] [PMID: 22532571]

Willis, C.M.; Ménoret, A.; Jellison, E.R.; Nicaise, A.M.; Vella, A.T.; Crocker, S.J. A refined bead-free method to identify astrocytic exo-somes in primary glial cultures and blood plasma. Front. Neurosci., 2017, 11, 335.
[http://dx.doi.org/10.3389/fnins.2017.00335] [PMID: 28663721]

Venturini, A.; Passalacqua, M.; Pelassa, S.; Pastorino, F.; Tedesco, M.; Cortese, K.; Gagliani, M.C.; Leo, G.; Maura, G.; Guidolin, D.; Ag-nati, L.F.; Marcoli, M.; Cervetto, C. Exosomes from astrocyte processes: Signaling to neurons. Front. Pharmacol., 2019, 10, 1452.
[http://dx.doi.org/10.3389/fphar.2019.01452] [PMID: 31849688]

Gosselin, R.D.; Meylan, P.; Decosterd, I. Extracellular microvesicles from astrocytes contain functional glutamate transporters: regulation by protein kinase C and cell activation. Front. Cell. Neurosci., 2013, 7, 251.
[http://dx.doi.org/10.3389/fncel.2013.00251] [PMID: 24368897]

Guitart, K.; Loers, G.; Buck, F.; Bork, U.; Schachner, M.; Kleene, R. Improvement of neuronal cell survival by astrocyte-derived exo-somes under hypoxic and ischemic conditions depends on prion protein. Glia, 2016, 64(6), 896-910.
[http://dx.doi.org/10.1002/glia.22963] [PMID: 26992135]

Kuhn, S.; Gritti, L.; Crooks, D.; Dombrowski, Y. Oligodendrocytes in development, myelin generation and beyond. Cells, 2019, 8(11), 8.
[http://dx.doi.org/10.3390/cells8111424] [PMID: 31726662]

Domingues, H.S.; Portugal, C.C.; Socodato, R.; Relvas, J.B. Corrigendum: Oligodendrocyte, astrocyte and microglia crosstalk in myelin development, damage, and repair. Front. Cell Dev. Biol., 2016, 4, 79.
[http://dx.doi.org/10.3389/fcell.2016.00079] [PMID: 27562149]

Frühbeis, C.; Fröhlich, D.; Kuo, W.P.; Amphornrat, J.; Thilemann, S.; Saab, A.S.; Kirchhoff, F.; Möbius, W.; Goebbels, S.; Nave, K.A.; Schneider, A.; Simons, M.; Klugmann, M.; Trotter, J.; Krämer-Albers, E.M. Neurotransmitter-triggered transfer of exosomes mediates oli-godendrocyte-neuron communication. PLoS Biol., 2013, 11(7), e1001604.
[http://dx.doi.org/10.1371/journal.pbio.1001604] [PMID: 23874151]

Fröhlich, D.; Kuo, W.P.; Frühbeis, C.; Sun, J.J.; Zehendner, C.M.; Luhmann, H.J.; Pinto, S.; Toedling, J.; Trotter, J.; Krämer-Albers, E.M. Multifaceted effects of oligodendroglial exosomes on neurons: impact on neuronal firing rate, signal transduction and gene regulation. Philos. Trans. R. Soc. Lond. B Biol. Sci., 2014, 369(1652), 369.
[http://dx.doi.org/10.1098/rstb.2013.0510] [PMID: 25135971]

Frühbeis, C.; Kuo-Elsner, W.P.; Barth, K.; Peris, L.; Tenzer, S.; Möbius, W.; Werner, H.B.; Nave, K-A.; Fröhlich, D.; Krämer-Albers, E-M. Oligodendrocyte-derived exosomes promote axonal transport and axonal long-term maintenance bioRxiv, 2019, 2019.12.20.884171.

Delpech, J.C.; Herron, S.; Botros, M.B.; Ikezu, T. Neuroimmune crosstalk through extracellular vesicles in health and disease. Trends Neurosci., 2019, 42(5), 361-372.
[http://dx.doi.org/10.1016/j.tins.2019.02.007] [PMID: 30926143]

Yin, J.; Valin, K.L.; Dixon, M.L.; Leavenworth, J.W. The role of microglia and macrophages in CNS homeostasis, autoimmunity, and cancer. J. Immunol. Res., 2017, 2017, 5150678.
[http://dx.doi.org/10.1155/2017/5150678] [PMID: 29410971]

Ueno, M.; Fujita, Y.; Tanaka, T.; Nakamura, Y.; Kikuta, J.; Ishii, M.; Yamashita, T. Layer V cortical neurons require microglial support for survival during postnatal development. Nat. Neurosci., 2013, 16(5), 543-551.
[http://dx.doi.org/10.1038/nn.3358] [PMID: 23525041]

Glebov, K.; Löchner, M.; Jabs, R.; Lau, T.; Merkel, O.; Schloss, P.; Steinhäuser, C.; Walter, J. Serotonin stimulates secretion of exosomes from microglia cells. Glia, 2015, 63(4), 626-634.
[http://dx.doi.org/10.1002/glia.22772] [PMID: 25451814]

Potolicchio, I.; Carven, G.J.; Xu, X.; Stipp, C.; Riese, R.J.; Stern, L.J.; Santambrogio, L. Proteomic analysis of microglia-derived exosomes: metabolic role of the aminopeptidase CD13 in neuropeptide catabolism. J. Immunol., 2005, 175(4), 2237-2243.
[http://dx.doi.org/10.4049/jimmunol.175.4.2237] [PMID: 16081791]

Drago, F.; Lombardi, M.; Prada, I.; Gabrielli, M.; Joshi, P.; Cojoc, D.; Franck, J.; Fournier, I.; Vizioli, J.; Verderio, C. ATP modifies the proteome of extracellular vesicles released by microglia and influences their action on astrocytes. Front. Pharmacol., 2017, 8, 910.
[http://dx.doi.org/10.3389/fphar.2017.00910] [PMID: 29321741]

Fauré, J.; Lachenal, G.; Court, M.; Hirrlinger, J.; Chatellard-Causse, C.; Blot, B.; Grange, J.; Schoehn, G.; Goldberg, Y.; Boyer, V.; Kirch-hoff, F.; Raposo, G.; Garin, J.; Sadoul, R. Exosomes are released by cultured cortical neurones. Mol. Cell. Neurosci., 2006, 31(4), 642-648.
[http://dx.doi.org/10.1016/j.mcn.2005.12.003] [PMID: 16446100]

Lachenal, G.; Pernet-Gallay, K.; Chivet, M.; Hemming, F.J.; Belly, A.; Bodon, G.; Blot, B.; Haase, G.; Goldberg, Y.; Sadoul, R. Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity. Mol. Cell. Neurosci., 2011, 46(2), 409-418.
[http://dx.doi.org/10.1016/j.mcn.2010.11.004] [PMID: 21111824]

Sharma, P.; Mesci, P.; Carromeu, C.; McClatchy, D.R.; Schiapparelli, L.; Yates, J.R., III; Muotri, A.R.; Cline, H.T. Exosomes regulate neu-rogenesis and circuit assembly. Proc. Natl. Acad. Sci. USA, 2019, 116(32), 16086-16094.
[http://dx.doi.org/10.1073/pnas.1902513116] [PMID: 31320591]

Bahrini, I.; Song, J.H.; Diez, D.; Hanayama, R. Neuronal exosomes facilitate synaptic pruning by up-regulating complement factors in microglia. Sci. Rep., 2015, 5, 7989.
[http://dx.doi.org/10.1038/srep07989] [PMID: 25612542]

Lee, S.; Mankhong, S.; Kang, J.H. Extracellular vesicle as a source of Alzheimer’s biomarkers: Opportunities and challenges. Int. J. Mol. Sci., 2019, 20(7), 20.
[http://dx.doi.org/10.3390/ijms20071728] [PMID: 30965555]

Corder, E.H.; Saunders, A.M.; Strittmatter, W.J.; Schmechel, D.E.; Gaskell, P.C.; Small, G.W.; Roses, A.D.; Haines, J.L.; Pericak-Vance, M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science, 1993, 261(5123), 921-923.
[http://dx.doi.org/10.1126/science.8346443] [PMID: 8346443]

Farrer, L.A.; Cupples, L.A.; Haines, J.L.; Hyman, B.; Kukull, W.A.; Mayeux, R.; Myers, R.H.; Pericak-Vance, M.A.; Risch, N.; van Duijn, C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. JAMA, 1997, 278(16), 1349-1356.
[http://dx.doi.org/10.1001/jama.1997.03550160069041] [PMID: 9343467]

Rajendran, L.; Honsho, M.; Zahn, T.R.; Keller, P.; Geiger, K.D.; Verkade, P.; Simons, K. Alzheimer’s disease beta-amyloid peptides are released in association with exosomes. Proc. Natl. Acad. Sci. USA, 2006, 103(30), 11172-11177.
[http://dx.doi.org/10.1073/pnas.0603838103] [PMID: 16837572]

Sharples, R.A.; Vella, L.J.; Nisbet, R.M.; Naylor, R.; Perez, K.; Barnham, K.J.; Masters, C.L.; Hill, A.F. Inhibition of gamma-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes. FASEB J., 2008, 22(5), 1469-1478.
[http://dx.doi.org/10.1096/fj.07-9357com] [PMID: 18171695]

Asai, H.; Ikezu, S.; Tsunoda, S.; Medalla, M.; Luebke, J.; Haydar, T.; Wolozin, B.; Butovsky, O.; Kügler, S.; Ikezu, T. Depletion of micro-glia and inhibition of exosome synthesis halt tau propagation. Nat. Neurosci., 2015, 18(11), 1584-1593.
[http://dx.doi.org/10.1038/nn.4132] [PMID: 26436904]

Dinkins, M.B.; Dasgupta, S.; Wang, G.; Zhu, G.; Bieberich, E. Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer’s disease. Neurobiol. Aging, 2014, 35(8), 1792-1800.
[http://dx.doi.org/10.1016/j.neurobiolaging.2014.02.012] [PMID: 24650793]

Serrano-Pozo, A.; Mielke, M.L.; Gómez-Isla, T.; Betensky, R.A.; Growdon, J.H.; Frosch, M.P.; Hyman, B.T. Reactive glia not only associ-ates with plaques but also parallels tangles in Alzheimer’s disease. Am. J. Pathol., 2011, 179(3), 1373-1384.
[http://dx.doi.org/10.1016/j.ajpath.2011.05.047] [PMID: 21777559]

Crotti, A.; Sait, H.R.; McAvoy, K.M.; Estrada, K.; Ergun, A.; Szak, S.; Marsh, G.; Jandreski, L.; Peterson, M.; Reynolds, T.L.; Dalkilic-Liddle, I.; Cameron, A.; Cahir-McFarland, E.; Ransohoff, R.M. BIN1 favors the spreading of Tau via extracellular vesicles. Sci. Rep., 2019, 9(1), 9477.
[http://dx.doi.org/10.1038/s41598-019-45676-0] [PMID: 31263146]

Nelson, P.T.; Wang, W.X. MiR-107 is reduced in Alzheimer’s disease brain neocortex: validation study. J. Alzheimers Dis., 2010, 21(1), 75-79.
[http://dx.doi.org/10.3233/JAD-2010-091603] [PMID: 20413881]

Zhu, H.C.; Wang, L.M.; Wang, M.; Song, B.; Tan, S.; Teng, J.F.; Duan, D.X. MicroRNA-195 downregulates Alzheimer’s disease amyloid-β production by targeting BACE1. Brain Res. Bull., 2012, 88(6), 596-601.
[http://dx.doi.org/10.1016/j.brainresbull.2012.05.018] [PMID: 22721728]

Kim, J.; Yoon, H.; Ramírez, C.M.; Lee, S.M.; Hoe, H.S.; Fernández-Hernando, C.; Kim, J. MiR-106b impairs cholesterol efflux and in-creases Aβ levels by repressing ABCA1 expression. Exp. Neurol., 2012, 235(2), 476-483.
[http://dx.doi.org/10.1016/j.expneurol.2011.11.010] [PMID: 22119192]

Ben Halima, S.; Siegel, G.; Rajendran, L. miR-186 in Alzheimer’s disease: a big hope for a small RNA? J. Neurochem., 2016, 137(3), 308-311.
[http://dx.doi.org/10.1111/jnc.13573] [PMID: 27029568]

Patel, N.; Hoang, D.; Miller, N.; Ansaloni, S.; Huang, Q.; Rogers, J.T.; Lee, J.C.; Saunders, A.J. MicroRNAs can regulate human APP lev-els. Mol. Neurodegener., 2008, 3, 10.
[http://dx.doi.org/10.1186/1750-1326-3-10] [PMID: 18684319]

Yang, L.B.; Lindholm, K.; Yan, R.; Citron, M.; Xia, W.; Yang, X.L.; Beach, T.; Sue, L.; Wong, P.; Price, D.; Li, R.; Shen, Y. Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat. Med., 2003, 9(1), 3-4.
[http://dx.doi.org/10.1038/nm0103-3] [PMID: 12514700]

Cogswell, J.P.; Ward, J.; Taylor, I.A.; Waters, M.; Shi, Y.; Cannon, B.; Kelnar, K.; Kemppainen, J.; Brown, D.; Chen, C.; Prinjha, R.K.; Richardson, J.C.; Saunders, A.M.; Roses, A.D.; Richards, C.A. Identification of miRNA changes in Alzheimer’s disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimers Dis., 2008, 14(1), 27-41.
[http://dx.doi.org/10.3233/JAD-2008-14103] [PMID: 18525125]

Sethi, P.; Lukiw, W.J. Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer’s disease temporal lobe neo-cortex. Neurosci. Lett., 2009, 459(2), 100-104.
[http://dx.doi.org/10.1016/j.neulet.2009.04.052] [PMID: 19406203]

Schonrock, N.; Ke, Y.D.; Humphreys, D.; Staufenbiel, M.; Ittner, L.M.; Preiss, T.; Götz, J. Neuronal microRNA deregulation in response to Alzheimer’s disease amyloid-beta. PLoS One, 2010, 5(6), e11070.
[http://dx.doi.org/10.1371/journal.pone.0011070] [PMID: 20552018]

Coolen, M.; Katz, S.; Bally-Cuif, L. miR-9: a versatile regulator of neurogenesis. Front. Cell. Neurosci., 2013, 7, 220.
[http://dx.doi.org/10.3389/fncel.2013.00220] [PMID: 24312010]

Schonrock, N.; Humphreys, D.T.; Preiss, T.; Götz, J. Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by amyloid-β. J. Mol. Neurosci., 2012, 46(2), 324-335.
[http://dx.doi.org/10.1007/s12031-011-9587-2] [PMID: 21720722]

Mairet-Coello, G.; Courchet, J.; Pieraut, S.; Courchet, V.; Maximov, A.; Polleux, F. The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Aβ oligomers through Tau phosphorylation. Neuron, 2013, 78(1), 94-108.
[http://dx.doi.org/10.1016/j.neuron.2013.02.003] [PMID: 23583109]

Wu, J.; Xie, X. Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression. Genome Biol., 2006, 7(9), R85.
[http://dx.doi.org/10.1186/gb-2006-7-9-r85] [PMID: 17002790]

Chang, F.; Zhang, L.H.; Xu, W.P.; Jing, P.; Zhan, P.Y. microRNA-9 attenuates amyloidβ-induced synaptotoxicity by targeting calci-um/calmodulin-dependent protein kinase kinase 2. Mol. Med. Rep., 2014, 9(5), 1917-1922.
[http://dx.doi.org/10.3892/mmr.2014.2013] [PMID: 24603903]

Wang, W.X.; Rajeev, B.W.; Stromberg, A.J.; Ren, N.; Tang, G.; Huang, Q.; Rigoutsos, I.; Nelson, P.T. The expression of microRNA miR-107 decreases early in Alzheimer’s disease and may accelerate disease progression through regulation of beta-site amyloid precursor pro-tein-cleaving enzyme 1. J. Neurosci., 2008, 28(5), 1213-1223.
[http://dx.doi.org/10.1523/JNEUROSCI.5065-07.2008] [PMID: 18234899]

Augustin, R.; Endres, K.; Reinhardt, S.; Kuhn, P.H.; Lichtenthaler, S.F.; Hansen, J.; Wurst, W.; Trümbach, D. Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10. BMC Med. Genet., 2012, 13, 35.
[http://dx.doi.org/10.1186/1471-2350-13-35] [PMID: 22594617]

Yao, J.; Hennessey, T.; Flynt, A.; Lai, E.; Beal, M.F.; Lin, M.T. MicroRNA-related cofilin abnormality in Alzheimer’s disease. PLoS One, 2010, 5(12), e15546.
[http://dx.doi.org/10.1371/journal.pone.0015546] [PMID: 21179570]

Vickrey, B.G.; Mittman, B.S.; Connor, K.I.; Pearson, M.L.; Della Penna, R.D.; Ganiats, T.G.; Demonte, R.W., Jr; Chodosh, J.; Cui, X.; Vassar, S.; Duan, N.; Lee, M. The effect of a disease management intervention on quality and outcomes of dementia care: a randomized, controlled trial. Ann. Intern. Med., 2006, 145(10), 713-726.
[http://dx.doi.org/10.7326/0003-4819-145-10-200611210-00004] [PMID: 17116916]

Voisin, T.; Vellas, B. Diagnosis and treatment of patients with severe Alzheimer’s disease. Drugs Aging, 2009, 26(2), 135-144.
[http://dx.doi.org/10.2165/0002512-200926020-00005] [PMID: 19220070]

Emamzadeh, F.N.; Surguchov, A. Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors. Front. Neurosci., 2018, 12, 612.
[http://dx.doi.org/10.3389/fnins.2018.00612] [PMID: 30214392]

Zafar, S.; Yaddanapudi, S.S. Parkinson Disease. StatPearls, 2021. StatPearls Publishing, 2022 Jan-. Available from: https://www. ncbi.nlm.nih.gov/books/NBK470193/

Poewe, W.; Seppi, K.; Tanner, C.M.; Halliday, G.M.; Brundin, P.; Volkmann, J.; Schrag, A.E.; Lang, A.E. Parkinson disease. Nat. Rev. Dis. Primers, 2017, 3, 17013.
[http://dx.doi.org/10.1038/nrdp.2017.13] [PMID: 28332488]

El-Agnaf, O.M.; Salem, S.A.; Paleologou, K.E.; Cooper, L.J.; Fullwood, N.J.; Gibson, M.J.; Curran, M.D.; Court, J.A.; Mann, D.M.; Ikeda, S.; Cookson, M.R.; Hardy, J.; Allsop, D. Alpha-synuclein implicated in Parkinson’s disease is present in extracellular biological fluids, in-cluding human plasma. FASEB J., 2003, 17(13), 1945-1947.
[http://dx.doi.org/10.1096/fj.03-0098fje] [PMID: 14519670]

Emmanouilidou, E.; Melachroinou, K.; Roumeliotis, T.; Garbis, S.D.; Ntzouni, M.; Margaritis, L.H.; Stefanis, L.; Vekrellis, K. Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J. Neurosci., 2010, 30(20), 6838-6851.
[http://dx.doi.org/10.1523/JNEUROSCI.5699-09.2010] [PMID: 20484626]

Alvarez-Erviti, L.; Seow, Y.; Schapira, A.H.; Gardiner, C.; Sargent, I.L.; Wood, M.J.; Cooper, J.M. Lysosomal dysfunction increases exo-some-mediated alpha-synuclein release and transmission. Neurobiol. Dis., 2011, 42(3), 360-367.
[http://dx.doi.org/10.1016/j.nbd.2011.01.029] [PMID: 21303699]

Danzer, K.M.; Kranich, L.R.; Ruf, W.P.; Cagsal-Getkin, O.; Winslow, A.R.; Zhu, L.; Vanderburg, C.R.; McLean, P.J. Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol. Neurodegener., 2012, 7, 42.
[http://dx.doi.org/10.1186/1750-1326-7-42] [PMID: 22920859]

Cao, Z. Wu, Y.; Liu, G.; Jiang, Y.; Wang, X.; Wang, Z.; Feng, T. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson’s disease. Neurosci. Lett., 2019, 696, 114-120.
[http://dx.doi.org/10.1016/j.neulet.2018.12.030] [PMID: 30579996]

Chang, C.; Lang, H.; Geng, N.; Wang, J.; Li, N.; Wang, X. Exosomes of BV-2 cells induced by alpha-synuclein: important mediator of neurodegeneration in PD. Neurosci. Lett., 2013, 548, 190-195.
[http://dx.doi.org/10.1016/j.neulet.2013.06.009] [PMID: 23792198]

Cooper, J.M.; Wiklander, P.B.; Nordin, J.Z.; Al-Shawi, R.; Wood, M.J.; Vithlani, M.; Schapira, A.H.; Simons, J.P.; El-Andaloussi, S. Alva-rez-Erviti, L. Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice. Mov. Disord., 2014, 29(12), 1476-1485.
[http://dx.doi.org/10.1002/mds.25978] [PMID: 25112864]

Haney, M.J.; Klyachko, N.L.; Zhao, Y.; Gupta, R.; Plotnikova, E.G.; He, Z.; Patel, T.; Piroyan, A.; Sokolsky, M.; Kabanov, A.V.; Batrako-va, E.V. Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J. Control. Release, 2015, 207, 18-30.
[http://dx.doi.org/10.1016/j.jconrel.2015.03.033] [PMID: 25836593]

Etheridge, A.; Lee, I.; Hood, L.; Galas, D.; Wang, K. Extracellular microRNA: a new source of biomarkers. Mutat. Res., 2011, 717(1-2), 85-90.
[http://dx.doi.org/10.1016/j.mrfmmm.2011.03.004] [PMID: 21402084]

Kamal, M.A.; Mushtaq, G.; Greig, N.H. Current update on synopsis of miRNA dysregulation in neurological disorders. CNS Neurol. Disord. Drug Targets, 2015, 14(4), 492-501.
[http://dx.doi.org/10.2174/1871527314666150225143637] [PMID: 25714967]

Palanichamy, J.K.; Rao, D.S. miRNA dysregulation in cancer: towards a mechanistic understanding. Front. Genet., 2014, 5, 54.
[http://dx.doi.org/10.3389/fgene.2014.00054] [PMID: 24672539]

Goh, S.Y.; Chao, Y.X.; Dheen, S.T.; Tan, E.K.; Tay, S.S. Role of MicroRNAs in Parkinson’s Disease. Int. J. Mol. Sci., 2019, 20(22), 20.
[http://dx.doi.org/10.3390/ijms20225649] [PMID: 31718095]

Miñones-Moyano, E.; Porta, S.; Escaramís, G.; Rabionet, R.; Iraola, S.; Kagerbauer, B.; Espinosa-Parrilla, Y.; Ferrer, I.; Estivill, X.; Martí, E. MicroRNA profiling of Parkinson’s disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial func-tion. Hum. Mol. Genet., 2011, 20(15), 3067-3078.
[http://dx.doi.org/10.1093/hmg/ddr210] [PMID: 21558425]

Cookson, M.R. Parkinsonism due to mutations in PINK1, parkin, and DJ-1 and oxidative stress and mitochondrial pathways. Cold Spring Harb. Perspect. Med., 2012, 2(9), a009415.
[http://dx.doi.org/10.1101/cshperspect.a009415] [PMID: 22951446]

Shimura, H.; Hattori, N.; Kubo, Si.; Mizuno, Y.; Asakawa, S.; Minoshima, S.; Shimizu, N.; Iwai, K.; Chiba, T.; Tanaka, K.; Suzuki, T. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet., 2000, 25(3), 302-305.
[http://dx.doi.org/10.1038/77060] [PMID: 10888878]

Illarioshkin, S.N.; Periquet, M.; Rawal, N.; Lücking, C.B.; Zagorovskaya, T.B.; Slominsky, P.A.; Miloserdova, O.V.; Markova, E.D.; Lim-borska, S.A.; Ivanova-Smolenskaya, I.A.; Brice, A. Mutation analysis of the parkin gene in Russian families with autosomal recessive ju-venile parkinsonism. Mov. Disord., 2003, 18(8), 914-919.
[http://dx.doi.org/10.1002/mds.10467] [PMID: 12889082]

Lindberg, I.; Shorter, J.; Wiseman, R.L.; Chiti, F.; Dickey, C.A.; McLean, P.J. Chaperones in Neurodegeneration. J. Neurosci., 2015, 35(41), 13853-13859.
[http://dx.doi.org/10.1523/JNEUROSCI.2600-15.2015] [PMID: 26468185]

Auluck, P.K.; Chan, H.Y.; Trojanowski, J.Q.; Lee, V.M.; Bonini, N.M. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson’s disease. Science, 2002, 295(5556), 865-868.
[http://dx.doi.org/10.1126/science.1067389] [PMID: 11823645]

Klucken, J.; Shin, Y.; Masliah, E.; Hyman, B.T.; McLean, P.J. Hsp70 Reduces alpha-Synuclein Aggregation and Toxicity. J. Biol. Chem., 2004, 279(24), 25497-25502.
[http://dx.doi.org/10.1074/jbc.M400255200] [PMID: 15044495]

Zhang, Z.; Cheng, Y. miR-16-1 promotes the aberrant α-synuclein accumulation in parkinson disease via targeting heat shock protein 70. Sci. World J., 2014, 2014, 938348.
[PMID: 25054189]

Alvarez-Erviti, L.; Seow, Y.; Schapira, A.H.; Rodriguez-Oroz, M.C.; Obeso, J.A.; Cooper, J.M. Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson’s disease. Cell Death Dis., 2013, 4, e545.
[http://dx.doi.org/10.1038/cddis.2013.73] [PMID: 23492776]

Kim, J.; Inoue, K.; Ishii, J.; Vanti, W.B.; Voronov, S.V.; Murchison, E.; Hannon, G.; Abeliovich, A. A MicroRNA feedback circuit in mid-brain dopamine neurons. Science, 2007, 317(5842), 1220-1224.
[http://dx.doi.org/10.1126/science.1140481] [PMID: 17761882]

Imran, M.; Mahmood, S. An overview of human prion diseases. Virol. J., 2011, 8, 559.
[http://dx.doi.org/10.1186/1743-422X-8-559] [PMID: 22196171]

Avni, A.; Swasthi, H.M.; Majumdar, A.; Mukhopadhyay, S. Intrinsically disordered proteins in the formation of functional amyloids from bacteria to humans. Prog. Mol. Biol. Transl. Sci., 2019, 166, 109-143.
[http://dx.doi.org/10.1016/bs.pmbts.2019.05.005] [PMID: 31521230]

Creutzfeldt, H.G. On a particular focal disease of the central nervous system (preliminary communication), 1920. Alzheimer Dis. Assoc. Disord., 1989, 3(1-2), 3-25.
[http://dx.doi.org/10.1097/00002093-198903010-00002] [PMID: 2663042]

Duckett, S.; Stern, J. Origins of the Creutzfeldt and Jakob concept. J. Hist. Neurosci., 1999, 8(1), 21-34.
[http://dx.doi.org/10.1076/jhin.8.1.21.1771] [PMID: 11624133]

Kübler, E.; Oesch, B.; Raeber, A.J. Diagnosis of prion diseases. Br. Med. Bull., 2003, 66, 267-279.
[http://dx.doi.org/10.1093/bmb/66.1.267] [PMID: 14522864]

Puckett, C.; Concannon, P.; Casey, C.; Hood, L. Genomic structure of the human prion protein gene. Am. J. Hum. Genet., 1991, 49(2), 320-329.
[PMID: 1678248]

Mackenzie, G.; Will, R. Creutzfeldt-Jakob disease: recent developments. F1000 Res., 2017, 6, 2053.
[http://dx.doi.org/10.12688/f1000research.12681.1] [PMID: 29225787]

Chen, C.; Dong, X.P. Epidemiological characteristics of human prion diseases. Infect. Dis. Poverty, 2016, 5(1), 47.
[http://dx.doi.org/10.1186/s40249-016-0143-8] [PMID: 27251305]

Mead, S.; Stumpf, M.P.; Whitfield, J.; Beck, J.A.; Poulter, M.; Campbell, T.; Uphill, J.B.; Goldstein, D.; Alpers, M.; Fisher, E.M.; Collinge, J. Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science, 2003, 300(5619), 640-643.
[http://dx.doi.org/10.1126/science.1083320] [PMID: 12690204]

Geschwind, M.D. Prion Diseases. Continuum (Minneap. Minn.), 2015, 21 (6 Neuroinfectious Disease), 1612-1638.
[http://dx.doi.org/10.1212/CON.0000000000000251] [PMID: 26633779]

Roos, R.; Gajdusek, D.C.; Gibbs, C.J., Jr The clinical characteristics of transmissible Creutzfeldt-Jakob disease. Brain, 1973, 96(1), 1-20.
[http://dx.doi.org/10.1093/brain/96.1.1] [PMID: 4633062]

Masters, C.L.; Gajdusek, D.C.; Gibbs, C.J. Jr Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain, 1981, 104(3), 559-588.
[http://dx.doi.org/10.1093/brain/104.3.559] [PMID: 6791762]

Colby, D.W.; Prusiner, S.B. Prions. Cold Spring Harb. Perspect. Biol., 2011, 3(1), a006833.
[http://dx.doi.org/10.1101/cshperspect.a006833] [PMID: 21421910]

Prusiner, S.B. Prions. Proc. Natl. Acad. Sci. USA, 1998, 95(23), 13363-13383.
[http://dx.doi.org/10.1073/pnas.95.23.13363] [PMID: 9811807]

Kosik, K.S. The neuronal microRNA system. Nat. Rev. Neurosci., 2006, 7(12), 911-920.
[http://dx.doi.org/10.1038/nrn2037] [PMID: 17115073]

Llorens, F.; Thüne, K.; Martí, E.; Kanata, E.; Dafou, D.; Díaz-Lucena, D.; Vivancos, A.; Shomroni, O.; Zafar, S.; Schmitz, M.; Michel, U.; Fernández-Borges, N.; Andréoletti, O.; Del Río, J.A.; Díez, J.; Fischer, A.; Bonn, S.; Sklaviadis, T.; Torres, J.M.; Ferrer, I.; Zerr, I. Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing ma-chinery and biogenesis. PLoS Pathog., 2018, 14(1), e1006802.
[http://dx.doi.org/10.1371/journal.ppat.1006802] [PMID: 29357384]

Gibbings, D.; Leblanc, P.; Jay, F.; Pontier, D.; Michel, F.; Schwab, Y.; Alais, S.; Lagrange, T.; Voinnet, O. Human prion protein binds Argonaute and promotes accumulation of microRNA effector complexes. Nat Struct Mol Biol, 2012, 19(5), 517-524. S1.
[http://dx.doi.org/10.1038/nsmb.2273] [PMID: 22484317]

Lukiw, W.J. Micro-RNA speciation in fetal, adult and Alzheimer’s disease hippocampus. Neuroreport, 2007, 18(3), 297-300.
[http://dx.doi.org/10.1097/WNR.0b013e3280148e8b] [PMID: 17314675]

Martins, M.; Rosa, A.; Guedes, L.C.; Fonseca, B.V.; Gotovac, K.; Violante, S.; Mestre, T.; Coelho, M.; Rosa, M.M.; Martin, E.R.; Vance, J.M.; Outeiro, T.F.; Wang, L.; Borovecki, F.; Ferreira, J.J.; Oliveira, S.A. Convergence of miRNA expression profiling, α-synuclein interac-ton and GWAS in Parkinson’s disease. PLoS One, 2011, 6(10), e25443.
[http://dx.doi.org/10.1371/journal.pone.0025443] [PMID: 22003392]

Bellingham, S.A.; Coleman, B.M.; Hill, A.F. Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res., 2012, 40(21), 10937-10949.
[http://dx.doi.org/10.1093/nar/gks832] [PMID: 22965126]

Boese, A.S.; Saba, R.; Campbell, K.; Majer, A.; Medina, S.; Burton, L.; Booth, T.F.; Chong, P.; Westmacott, G.; Dutta, S.M.; Saba, J.A.; Booth, S.A. MicroRNA abundance is altered in synaptoneurosomes during prion disease. Mol. Cell. Neurosci., 2016, 71, 13-24.
[http://dx.doi.org/10.1016/j.mcn.2015.12.001] [PMID: 26658803]

Lukiw, W.J.; Dua, P.; Pogue, A.I.; Eicken, C.; Hill, J.M. Upregulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neu-rodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syndrome. J. Toxicol. Environ. Health A, 2011, 74(22-24), 1460-1468.
[http://dx.doi.org/10.1080/15287394.2011.618973] [PMID: 22043907]

Montag, J.; Hitt, R.; Opitz, L.; Schulz-Schaeffer, W.J.; Hunsmann, G.; Motzkus, D. Upregulation of miRNA hsa-miR-342-3p in experi-mental and idiopathic prion disease. Mol. Neurodegener., 2009, 4, 36.
[http://dx.doi.org/10.1186/1750-1326-4-36] [PMID: 19712440]

Saba, R.; Goodman, C.D.; Huzarewich, R.L.; Robertson, C.; Booth, S.A. A miRNA signature of prion induced neurodegeneration. PLoS One, 2008, 3(11), e3652.
[http://dx.doi.org/10.1371/journal.pone.0003652] [PMID: 18987751]

Saba, R.; Gushue, S.; Huzarewich, R.L.; Manguiat, K.; Medina, S.; Robertson, C.; Booth, S.A. MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state. PLoS One, 2012, 7(2), e30832.
[http://dx.doi.org/10.1371/journal.pone.0030832] [PMID: 22363497]

Vinken, P.J.; Bruyn, G.W.; Klawans, H.L. Handbook of clinical neurology, North-Holland, c: Amsterdam. 1968.

Myers, R.H. Huntington’s disease genetics. NeuroRx, 2004, 1(2), 255-262.
[http://dx.doi.org/10.1602/neurorx.1.2.255] [PMID: 15717026]

MacDonald, M.E.; Ambrose, C.M.; Duyao, M.P.; Datson, N.; Shaw, D.; Harper, P.S. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 1993, 72(6), 971-983.
[http://dx.doi.org/10.1016/0092-8674(93)90585-E] [PMID: 8458085]

Duyao, M.; Ambrose, C.; Myers, R.; Novelletto, A.; Persichetti, F.; Frontali, M.; Folstein, S.; Ross, C.; Franz, M.; Abbott, M. Trinucleotide repeat length instability and age of onset in Huntington’s disease. Nat. Genet., 1993, 4(4), 387-392.
[http://dx.doi.org/10.1038/ng0893-387] [PMID: 8401587]

Wilson, C.M.; Mushtaq, G.; Kamal, M.A.; Terro, F. The Role of Endoproteolytic Processing in Neurodegeneration. CNS Neurol. Disord. Drug Targets, 2016, 15(10), 1222-1230.
[http://dx.doi.org/10.2174/1871527315666160922163511] [PMID: 27667336]

Yamamoto, A.; Lucas, J.J.; Hen, R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington’s disease. Cell, 2000, 101(1), 57-66.
[http://dx.doi.org/10.1016/S0092-8674(00)80623-6] [PMID: 10778856]

Hodges, A.; Strand, A.D.; Aragaki, A.K.; Kuhn, A.; Sengstag, T.; Hughes, G.; Elliston, L.A.; Hartog, C.; Goldstein, D.R.; Thu, D.; Hol-lingsworth, Z.R.; Collin, F.; Synek, B.; Holmans, P.A.; Young, A.B.; Wexler, N.S.; Delorenzi, M.; Kooperberg, C.; Augood, S.J.; Faull, R.L.; Olson, J.M.; Jones, L.; Luthi-Carter, R. Regional and cellular gene expression changes in human Huntington’s disease brain. Hum. Mol. Genet., 2006, 15(6), 965-977.
[http://dx.doi.org/10.1093/hmg/ddl013] [PMID: 16467349]

Zuccato, C.; Belyaev, N.; Conforti, P.; Ooi, L.; Tartari, M.; Papadimou, E.; MacDonald, M.; Fossale, E.; Zeitlin, S.; Buckley, N.; Cattaneo, E. Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington’s disease. J. Neurosci., 2007, 27(26), 6972-6983.
[http://dx.doi.org/10.1523/JNEUROSCI.4278-06.2007] [PMID: 17596446]

Zuccato, C.; Tartari, M.; Crotti, A.; Goffredo, D.; Valenza, M.; Conti, L.; Cataudella, T.; Leavitt, B.R.; Hayden, M.R.; Timmusk, T.; Riga-monti, D.; Cattaneo, E. Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat. Genet., 2003, 35(1), 76-83.
[http://dx.doi.org/10.1038/ng1219] [PMID: 12881722]

Johnson, R.; Buckley, N.J. Gene dysregulation in Huntington’s disease: REST, microRNAs and beyond. Neuromolecular Med., 2009, 11(3), 183-199.
[http://dx.doi.org/10.1007/s12017-009-8063-4] [PMID: 19458943]

Johnson, R.; Teh, C.H.; Jia, H.; Vanisri, R.R.; Pandey, T.; Lu, Z.H.; Buckley, N.J.; Stanton, L.W.; Lipovich, L. Regulation of neural macroRNAs by the transcriptional repressor REST. RNA, 2009, 15(1), 85-96.
[http://dx.doi.org/10.1261/rna.1127009] [PMID: 19050060]

Martí, E.; Pantano, L.; Bañez-Coronel, M.; Llorens, F.; Miñones-Moyano, E.; Porta, S.; Sumoy, L.; Ferrer, I.; Estivill, X. A myriad of miRNA variants in control and Huntington’s disease brain regions detected by massively parallel sequencing. Nucleic Acids Res., 2010, 38(20), 7219-7235.
[http://dx.doi.org/10.1093/nar/gkq575] [PMID: 20591823]

Shah, S.Z.A.; Zhao, D.; Hussain, T.; Sabir, N.; Yang, L. Regulation of MicroRNAs-Mediated Autophagic Flux: A New Regulatory Avenue for Neurodegenerative Diseases With Focus on Prion Diseases. Front. Aging Neurosci., 2018, 10, 139.
[http://dx.doi.org/10.3389/fnagi.2018.00139] [PMID: 29867448]

Lee, S.T.; Chu, K. Im, W.S.; Yoon, H.J.; Im, J.Y.; Park, J.E.; Park, K.H.; Jung, K.H.; Lee, S.K.; Kim, M.; Roh, J.K. Altered microRNA regulation in Huntington’s disease models. Exp. Neurol., 2011, 227(1), 172-179.
[http://dx.doi.org/10.1016/j.expneurol.2010.10.012] [PMID: 21035445]

Kocerha, J.; Xu, Y.; Prucha, M.S.; Zhao, D.; Chan, A.W. microRNA-128a dysregulation in transgenic Huntington’s disease monkeys. Mol. Brain, 2014, 7, 46.
[http://dx.doi.org/10.1186/1756-6606-7-46] [PMID: 24929669]

Johnson, R.; Zuccato, C.; Belyaev, N.D.; Guest, D.J.; Cattaneo, E.; Buckley, N.J. A microRNA-based gene dysregulation pathway in Hun-tington’s disease. Neurobiol. Dis., 2008, 29(3), 438-445.
[http://dx.doi.org/10.1016/j.nbd.2007.11.001] [PMID: 18082412]

Das, E.; Jana, N.R.; Bhattacharyya, N.P. MicroRNA-124 targets CCNA2 and regulates cell cycle in STHdh(Q111)/Hdh(Q111) cells. Biochem. Biophys. Res. Commun., 2013, 437(2), 217-224.
[http://dx.doi.org/10.1016/j.bbrc.2013.06.041] [PMID: 23796713]

Rowland, L.P.; Shneider, N.A. Amyotrophic lateral sclerosis. N. Engl. J. Med., 2001, 344(22), 1688-1700.
[http://dx.doi.org/10.1056/NEJM200105313442207] [PMID: 11386269]

Talbot, K. Motor neuron disease: the bare essentials. Pract. Neurol., 2009, 9(5), 303-309.
[http://dx.doi.org/10.1136/jnnp.2009.188151] [PMID: 19762894]

Pupillo, E.; Messina, P.; Logroscino, G.; Beghi, E. Long-term survival in amyotrophic lateral sclerosis: a population-based study. Ann. Neurol., 2014, 75(2), 287-297.
[http://dx.doi.org/10.1002/ana.24096] [PMID: 24382602]

Martin, S.; Al Khleifat, A.; Al-Chalabi, A. What causes amyotrophic lateral sclerosis? F1000 Res., 2017, 6, 371.
[http://dx.doi.org/10.12688/f1000research.10476.1] [PMID: 28408982]

Al-Chalabi, A.; van den Berg, L.H.; Veldink, J. Gene discovery in amyotrophic lateral sclerosis: implications for clinical management. Nat. Rev. Neurol., 2017, 13(2), 96-104.
[http://dx.doi.org/10.1038/nrneurol.2016.182] [PMID: 27982040]

Liu, Z.J.; Li, H.F.; Tan, G.H.; Tao, Q.Q.; Ni, W.; Cheng, X.W.; Xiong, Z.Q.; Wu, Z.Y. Identify mutation in amyotrophic lateral sclerosis cases using HaloPlex target enrichment system. Neurobiol. Aging, 2014, 35(12), 2881.e11-2881.e15.
[http://dx.doi.org/10.1016/j.neurobiolaging.2014.07.003] [PMID: 25109764]

Neumann, M.; Sampathu, D.M.; Kwong, L.K.; Truax, A.C.; Micsenyi, M.C.; Chou, T.T.; Bruce, J.; Schuck, T.; Grossman, M.; Clark, C.M.; McCluskey, L.F.; Miller, B.L.; Masliah, E.; Mackenzie, I.R.; Feldman, H.; Feiden, W.; Kretzschmar, H.A.; Trojanowski, J.Q.; Lee, V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 2006, 314(5796), 130-133.
[http://dx.doi.org/10.1126/science.1134108] [PMID: 17023659]

Arai, T.; Hasegawa, M.; Akiyama, H.; Ikeda, K.; Nonaka, T.; Mori, H.; Mann, D.; Tsuchiya, K.; Yoshida, M.; Hashizume, Y.; Oda, T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclero-sis. Biochem. Biophys. Res. Commun., 2006, 351(3), 602-611.
[http://dx.doi.org/10.1016/j.bbrc.2006.10.093] [PMID: 17084815]

Majounie, E.; Renton, A.E.; Mok, K.; Dopper, E.G.; Waite, A.; Rollinson, S.; Chiò, A.; Restagno, G.; Nicolaou, N.; Simon-Sanchez, J.; van Swieten, J.C.; Abramzon, Y.; Johnson, J.O.; Sendtner, M.; Pamphlett, R.; Orrell, R.W.; Mead, S.; Sidle, K.C.; Houlden, H.; Rohrer, J.D.; Morrison, K.E.; Pall, H.; Talbot, K.; Ansorge, O.; Hernandez, D.G.; Arepalli, S.; Sabatelli, M.; Mora, G.; Corbo, M.; Giannini, F.; Calvo, A.; Englund, E.; Borghero, G.; Floris, G.L.; Remes, A.M.; Laaksovirta, H.; McCluskey, L.; Trojanowski, J.Q.; Van Deerlin, V.M.; Schel-lenberg, G.D.; Nalls, M.A.; Drory, V.E.; Lu, C.S.; Yeh, T.H.; Ishiura, H.; Takahashi, Y.; Tsuji, S.; Le Ber, I.; Brice, A.; Drepper, C.; Wil-liams, N.; Kirby, J.; Shaw, P.; Hardy, J.; Tienari, P.J.; Heutink, P.; Morris, H.R.; Pickering-Brown, S.; Traynor, B.J. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol., 2012, 11(4), 323-330.
[http://dx.doi.org/10.1016/S1474-4422(12)70043-1] [PMID: 22406228]

Benussi, L.; Rossi, G.; Glionna, M.; Tonoli, E.; Piccoli, E.; Fostinelli, S.; Paterlini, A.; Flocco, R.; Albani, D.; Pantieri, R.; Cereda, C.; For-loni, G.; Tagliavini, F.; Binetti, G.; Ghidoni, R. C9ORF72 hexanucleotide repeat number in frontotemporal lobar degeneration: a genotype-phenotype correlation study. J. Alzheimers Dis., 2014, 38(4), 799-808.
[http://dx.doi.org/10.3233/JAD-131028] [PMID: 24064469]

Volk, A.E.; Weishaupt, J.H.; Andersen, P.M.; Ludolph, A.C.; Kubisch, C. Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis. Med. Genetik, 2018, 30(2), 252-258.
[http://dx.doi.org/10.1007/s11825-018-0185-3] [PMID: 30220791]

Walker, C.; Herranz-Martin, S.; Karyka, E.; Liao, C.; Lewis, K.; Elsayed, W.; Lukashchuk, V.; Chiang, S.C.; Ray, S.; Mulcahy, P.J.; Jurga, M.; Tsagakis, I.; Iannitti, T.; Chandran, J.; Coldicott, I.; De Vos, K.J.; Hassan, M.K.; Higginbottom, A.; Shaw, P.J.; Hautbergue, G.M.; Az-zouz, M.; El-Khamisy, S.F. C9orf72 expansion disrupts ATM-mediated chromosomal break repair. Nat. Neurosci., 2017, 20(9), 1225-1235.
[http://dx.doi.org/10.1038/nn.4604] [PMID: 28714954]

Taylor, J.P.; Brown, R.H., Jr; Cleveland, D.W. Decoding ALS: from genes to mechanism. Nature, 2016, 539(7628), 197-206.
[http://dx.doi.org/10.1038/nature20413] [PMID: 27830784]

Batra, G.; Jain, M.; Singh, R.S.; Sharma, A.R.; Singh, A.; Prakash, A.; Medhi, B. Novel therapeutic targets for amyotrophic lateral sclerosis. Indian J. Pharmacol., 2019, 51(6), 418-425.
[http://dx.doi.org/10.4103/ijp.IJP_823_19] [PMID: 32029967]

García, M.L.; Fernández, A.; Solas, M.T. Mitochondria, motor neurons and aging. J. Neurol. Sci., 2013, 330(1-2), 18-26.
[http://dx.doi.org/10.1016/j.jns.2013.03.019] [PMID: 23628465]

Ono, Y.; Tanaka, H.; Takata, M.; Nagahara, Y.; Noda, Y.; Tsuruma, K.; Shimazawa, M.; Hozumi, I.; Hara, H. SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models. Neurosci. Lett., 2014, 559, 174-178.
[http://dx.doi.org/10.1016/j.neulet.2013.12.005] [PMID: 24334165]

Foran, E.; Trotti, D. Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis. Antioxid. Redox Signal., 2009, 11(7), 1587-1602.
[http://dx.doi.org/10.1089/ars.2009.2444] [PMID: 19413484]

Lin, C.L.; Bristol, L.A.; Jin, L.; Dykes-Hoberg, M.; Crawford, T.; Clawson, L.; Rothstein, J.D. Aberrant RNA processing in a neurodegen-erative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron, 1998, 20(3), 589-602.
[http://dx.doi.org/10.1016/S0896-6273(00)80997-6] [PMID: 9539131]

Blokhuis, A.M.; Groen, E.J.; Koppers, M.; van den Berg, L.H.; Pasterkamp, R.J. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol., 2013, 125(6), 777-794.
[http://dx.doi.org/10.1007/s00401-013-1125-6] [PMID: 23673820]

Gagliardi, D.; Comi, G.P.; Bresolin, N.; Corti, S. MicroRNAs as regulators of cell death mechanisms in amyotrophic lateral sclerosis. J. Cell. Mol. Med., 2019, 23(3), 1647-1656.
[http://dx.doi.org/10.1111/jcmm.13976] [PMID: 30614179]

Rizzuti, M.; Filosa, G.; Melzi, V.; Calandriello, L.; Dioni, L.; Bollati, V.; Bresolin, N.; Comi, G.P.; Barabino, S.; Nizzardo, M.; Corti, S. MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors. Sci. Rep., 2018, 8(1), 10105.
[http://dx.doi.org/10.1038/s41598-018-28366-1] [PMID: 29973608]

Li, L.H.; Tu, Q.Y.; Deng, X.H.; Xia, J.; Hou, D.R.; Guo, K.; Zi, X.H. Mutant presenilin2 promotes apoptosis through the p53/miR-34a axis in neuronal cells. Brain Res., 2017, 1662, 57-64.
[http://dx.doi.org/10.1016/j.brainres.2017.01.034] [PMID: 28189560]

McCubrey, J.A.; Fitzgerald, T.L.; Yang, L.V.; Lertpiriyapong, K.; Steelman, L.S.; Abrams, S.L.; Montalto, G.; Cervello, M.; Neri, L.M.; Cocco, L.; Martelli, A.M.; Laidler, P. Dulińska-Litewka, J.; Rakus, D.; Gizak, A.; Nicoletti, F.; Falzone, L.; Candido, S.; Libra, M. Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells. Oncotarget, 2017, 8(8), 14221-14250.
[http://dx.doi.org/10.18632/oncotarget.13991] [PMID: 27999207]

Waller, R.; Wyles, M.; Heath, P.R.; Kazoka, M.; Wollff, H.; Shaw, P.J.; Kirby, J.; Small, R.N.A. Sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed miRNAs related to neural and glial activity. Front. Neurosci., 2018, 11, 731.
[http://dx.doi.org/10.3389/fnins.2017.00731] [PMID: 29375285]

Wang, N.; Zhang, L.; Lu, Y.; Zhang, M.; Zhang, Z.; Wang, K.; Lv, J. Down-regulation of microRNA-142-5p attenuates oxygen-glucose deprivation and reoxygenation-induced neuron injury through up-regulating Nrf2/ARE signaling pathway. Biomed. Pharmacother., 2017, 89, 1187-1195.
[http://dx.doi.org/10.1016/j.biopha.2017.03.011] [PMID: 28320085]

Grad, L.I.; Yerbury, J.J.; Turner, B.J.; Guest, W.C.; Pokrishevsky, E.; O’Neill, M.A.; Yanai, A.; Silverman, J.M.; Zeineddine, R.; Corcoran, L.; Kumita, J.R.; Luheshi, L.M.; Yousefi, M.; Coleman, B.M.; Hill, A.F.; Plotkin, S.S.; Mackenzie, I.R.; Cashman, N.R. Intercellular propa-gated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. USA, 2014, 111(9), 3620-3625.
[http://dx.doi.org/10.1073/pnas.1312245111] [PMID: 24550511]

Compston, A.; Coles, A. Multiple sclerosis. Lancet, 2008, 372(9648), 1502-1517.
[http://dx.doi.org/10.1016/S0140-6736(08)61620-7] [PMID: 18970977]

Weinshenker, B.G. Epidemiology of multiple sclerosis. Neurol. Clin., 1996, 14(2), 291-308.
[http://dx.doi.org/10.1016/S0733-8619(05)70257-7] [PMID: 8827172]

Brust, C.M. Current diagnosis & treatment in neurology, 2nd ed; McGraw-Hill Medical: New York, 2012.

Koch-Henriksen, N.; Sørensen, P.S. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol., 2010, 9(5), 520-532.
[http://dx.doi.org/10.1016/S1474-4422(10)70064-8] [PMID: 20398859]

Kurtzke, J.F. Epidemiology of multiple sclerosis. Does this really point toward an etiology? Lectio Doctoralis. Neurol. Sci., 2000, 21(6), 383-403.
[http://dx.doi.org/10.1007/s100720070055] [PMID: 11441577]

Ghasemi, N.; Razavi, S.; Nikzad, E. Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy. Cell J., 2017, 19(1), 1-10.
[PMID: 28367411]

de Sa, J.C.; Airas, L.; Bartholome, E.; Grigoriadis, N.; Mattle, H.; Oreja-Guevara, C.; O’Riordan, J.; Sellebjerg, F.; Stankoff, B.; Vass, K.; Walczak, A.; Wiendl, H.; Kieseier, B.C. Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice. Ther. Adv. Neurol. Disord., 2011, 4(3), 139-168.
[http://dx.doi.org/10.1177/1756285611403646] [PMID: 21694816]

Holland, B.E. Factors affecting quality of life in persons with multiple sclerosis. The University of Texas at Arlington; The University of Texas: Texas, 2014, p. 116.

Huang, W.J.; Chen, W.W.; Zhang, X. Multiple sclerosis: Pathology, diagnosis and treatments. Exp. Ther. Med., 2017, 13(6), 3163-3166.
[http://dx.doi.org/10.3892/etm.2017.4410] [PMID: 28588671]

Weiner, H.L. A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis. J. Neurol., 2008, 255(Suppl. 1), 3-11.
[http://dx.doi.org/10.1007/s00415-008-1002-8] [PMID: 18317671]

Gandhi, R.; Laroni, A.; Weiner, H.L. Role of the innate immune system in the pathogenesis of multiple sclerosis. J. Neuroimmunol., 2010, 221(1-2), 7-14.
[http://dx.doi.org/10.1016/j.jneuroim.2009.10.015] [PMID: 19931190]

Kasper, L.H.; Shoemaker, J. Multiple sclerosis immunology: The healthy immune system vs. the MS immune system. Neurology, 2010, 74(Suppl. 1), S2-S8.
[http://dx.doi.org/10.1212/WNL.0b013e3181c97c8f] [PMID: 20038759]

Kouchaki, E.; Salehi, M.; Reza Sharif, M.; Nikoueinejad, H.; Akbari, H. Numerical status of CD4+CD25+FoxP3+ and CD8+CD28- regulatory T cells in multiple sclerosis. Iran. J. Basic Med. Sci., 2014, 17(4), 250-255.
[PMID: 24904717]

Olah, M.; Amor, S.; Brouwer, N.; Vinet, J.; Eggen, B.; Biber, K.; Boddeke, H.W. Identification of a microglia phenotype supportive of remyelination. Glia, 2012, 60(2), 306-321.
[http://dx.doi.org/10.1002/glia.21266] [PMID: 22072381]

Roumier, A.; Béchade, C.; Poncer, J.C.; Smalla, K.H.; Tomasello, E.; Vivier, E.; Gundelfinger, E.D.; Triller, A.; Bessis, A. Impaired synap-tic function in the microglial KARAP/DAP12-deficient mouse. J. Neurosci., 2004, 24(50), 11421-11428.
[http://dx.doi.org/10.1523/JNEUROSCI.2251-04.2004] [PMID: 15601948]

Wake, H.; Moorhouse, A.J.; Jinno, S.; Kohsaka, S.; Nabekura, J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci., 2009, 29(13), 3974-3980.
[http://dx.doi.org/10.1523/JNEUROSCI.4363-08.2009] [PMID: 19339593]

Blonda, M.; Amoruso, A.; Grasso, R.; Di Francescantonio, V.; Avolio, C. Multiple sclerosis treatments affect monocyte-derived mi-crovesicle production. Front. Neurol., 2017, 8, 422.
[http://dx.doi.org/10.3389/fneur.2017.00422] [PMID: 28878732]

Roberts, C.T., Jr; Kurre, P. Vesicle trafficking and RNA transfer add complexity and connectivity to cell-cell communication. Cancer Res., 2013, 73(11), 3200-3205.
[http://dx.doi.org/10.1158/0008-5472.CAN-13-0265] [PMID: 23695552]

Vickers, K.C.; Palmisano, B.T.; Shoucri, B.M.; Shamburek, R.D.; Remaley, A.T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol., 2011, 13(4), 423-433.
[http://dx.doi.org/10.1038/ncb2210] [PMID: 21423178]

Vickers, K.C.; Remaley, A.T. Lipid-based carriers of microRNAs and intercellular communication. Curr. Opin. Lipidol., 2012, 23(2), 91-97.
[http://dx.doi.org/10.1097/MOL.0b013e328350a425] [PMID: 22418571]

Gallo, A.; Tandon, M.; Alevizos, I.; Illei, G.G. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One, 2012, 7(3), e30679.
[http://dx.doi.org/10.1371/journal.pone.0030679] [PMID: 22427800]

Kanada, M.; Bachmann, M.H.; Hardy, J.W.; Frimannson, D.O.; Bronsart, L.; Wang, A.; Sylvester, M.D.; Schmidt, T.L.; Kaspar, R.L.; Butte, M.J.; Matin, A.C.; Contag, C.H. Differential fates of biomolecules delivered to target cells via extracellular vesicles. Proc. Natl. Acad. Sci. USA, 2015, 112(12), E1433-E1442.
[http://dx.doi.org/10.1073/pnas.1418401112] [PMID: 25713383]

Sáenz-Cuesta, M.; Osorio-Querejeta, I.; Otaegui, D. Extracellular vesicles in multiple sclerosis: What are they telling us? Front. Cell. Neurosci., 2014, 8, 100.
[http://dx.doi.org/10.3389/fncel.2014.00100] [PMID: 24734004]

Zare-Shahabadi, A.; Renaudineau, Y.; Rezaei, N. MicroRNAs and multiple sclerosis: from physiopathology toward therapy. Expert Opin. Ther. Targets, 2013, 17(12), 1497-1507.
[http://dx.doi.org/10.1517/14728222.2013.838219] [PMID: 24053428]

Jagot, F.; Davoust, N. Is It worth Considering Circulating microRNAs in Multiple Sclerosis? Front. Immunol., 2016, 7, 129.
[http://dx.doi.org/10.3389/fimmu.2016.00129] [PMID: 27092141]

Emery, B. Regulation of oligodendrocyte differentiation and myelination. Science, 2010, 330(6005), 779-782.
[http://dx.doi.org/10.1126/science.1190927] [PMID: 21051629]

Xiao, C.; Rajewsky, K. MicroRNA control in the immune system: basic principles. Cell, 2009, 136(1), 26-36.
[http://dx.doi.org/10.1016/j.cell.2008.12.027] [PMID: 19135886]

Regev, K.; Healy, B.C.; Paul, A.; Diaz-Cruz, C.; Mazzola, M.A.; Raheja, R.; Glanz, B.I.; Kivisäkk, P.; Chitnis, T.; Jagodic, M.; Piehl, F.; Olsson, T.; Khademi, M.; Hauser, S.; Oksenberg, J.; Khoury, S.J.; Weiner, H.L.; Gandhi, R. Identification of MS-specific serum miRNAs in an international multicenter study. Neurol. Neuroimmunol. Neuroinflamm., 2018, 5(5), e491.
[http://dx.doi.org/10.1212/NXI.0000000000000491] [PMID: 30175165]

Cheng, L.C.; Pastrana, E.; Tavazoie, M.; Doetsch, F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat. Neurosci., 2009, 12(4), 399-408.
[http://dx.doi.org/10.1038/nn.2294] [PMID: 19287386]

Du, C.; Liu, C.; Kang, J.; Zhao, G.; Ye, Z.; Huang, S.; Li, Z.; Wu, Z.; Pei, G. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat. Immunol., 2009, 10(12), 1252-1259.
[http://dx.doi.org/10.1038/ni.1798] [PMID: 19838199]

Eve, D.J.; Marty, P.J.; McDermott, R.J.; Klasko, S.K.; Sanberg, P. Resource for stem cell research. Am. J. Health Educ., 2008, 39(3), 167-179.

Ma, D.K.; Bonaguidi, M.A.; Ming, G.L.; Song, H. Adult neural stem cells in the mammalian central nervous system. Cell Res., 2009, 19(6), 672-682.
[http://dx.doi.org/10.1038/cr.2009.56] [PMID: 19436263]

Drukker, M.; Katz, G.; Urbach, A.; Schuldiner, M.; Markel, G.; Itskovitz-Eldor, J.; Reubinoff, B.; Mandelboim, O.; Benvenisty, N. Charac-terization of the expression of MHC proteins in human embryonic stem cells. Proc. Natl. Acad. Sci. USA, 2002, 99(15), 9864-9869.
[http://dx.doi.org/10.1073/pnas.142298299] [PMID: 12114532]

Biehl, J.K.; Russell, B. Introduction to stem cell therapy. J. Cardiovasc. Nurs., 2009, 24(2), 98-103.
[http://dx.doi.org/10.1097/JCN.0b013e318197a6a5] [PMID: 19242274]

Jaenisch, R.; Young, R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell, 2008, 132(4), 567-582.
[http://dx.doi.org/10.1016/j.cell.2008.01.015] [PMID: 18295576]

Marson, A.; Levine, S.S.; Cole, M.F.; Frampton, G.M.; Brambrink, T.; Johnstone, S.; Guenther, M.G.; Johnston, W.K.; Wernig, M.; New-man, J.; Calabrese, J.M.; Dennis, L.M.; Volkert, T.L.; Gupta, S.; Love, J.; Hannett, N.; Sharp, P.A.; Bartel, D.P.; Jaenisch, R.; Young, R.A. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell, 2008, 134(3), 521-533.
[http://dx.doi.org/10.1016/j.cell.2008.07.020] [PMID: 18692474]

Alhadlaq, A.; Mao, J.J. Tissue-engineered osteochondral constructs in the shape of an articular condyle. J. Bone Joint Surg. Am., 2005, 87(5), 936-944.
[http://dx.doi.org/10.2106/JBJS.D.02104] [PMID: 15866954]

Madrazo, I.; Drucker-Colín, R.; Díaz, V.; Martínez-Mata, J.; Torres, C.; Becerril, J.J. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson’s disease. N. Engl. J. Med., 1987, 316(14), 831-834.
[http://dx.doi.org/10.1056/NEJM198704023161402] [PMID: 3821826]

Barker, R.A.; Parmar, M.; Studer, L.; Takahashi, J. Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson’s Disease: Dawn of a New Era. Cell Stem Cell, 2017, 21(5), 569-573.
[http://dx.doi.org/10.1016/j.stem.2017.09.014] [PMID: 29100010]

Kirkeby, A.; Parmar, M.; Barker, R.A. Strategies for bringing stem cell-derived dopamine neurons to the clinic: A European approach (STEM-PD). In: Prog. Brain Res; , 2017; 230, pp. 165-190.
[http://dx.doi.org/10.1016/bs.pbr.2016.11.011] [PMID: 28552228]

Yu, D.X.; Marchetto, M.C.; Gage, F.H. Therapeutic translation of iPSCs for treating neurological disease. Cell Stem Cell, 2013, 12(6), 678-688.
[http://dx.doi.org/10.1016/j.stem.2013.05.018] [PMID: 23746977]

Kang, J.M.; Yeon, B.K.; Cho, S.J.; Suh, Y.H. Stem Cell Therapy for Alzheimer’s Disease: A Review of Recent Clinical Trials. J. Alzheimers Dis., 2016, 54(3), 879-889.
[http://dx.doi.org/10.3233/JAD-160406] [PMID: 27567851]

Xuan, A.G.; Luo, M.; Ji, W.D.; Long, D.H. Effects of engrafted neural stem cells in Alzheimer’s disease rats. Neurosci. Lett., 2009, 450(2), 167-171.
[http://dx.doi.org/10.1016/j.neulet.2008.12.001] [PMID: 19070649]

Marks, P.W.; Witten, C.M.; Califf, R.M. Clarifying Stem-Cell Therapy’s Benefits and Risks. N. Engl. J. Med., 2017, 376(11), 1007-1009.
[http://dx.doi.org/10.1056/NEJMp1613723] [PMID: 27959704]

Stuckey, D.W.; Shah, K. Stem cell-based therapies for cancer treatment: separating hope from hype. Nat. Rev. Cancer, 2014, 14(10), 683-691.
[http://dx.doi.org/10.1038/nrc3798] [PMID: 25176333]

Granero-Molto, F.; Weis, J.A.; Longobardi, L.; Spagnoli, A. Role of mesenchymal stem cells in regenerative medicine: application to bone and cartilage repair. Expert Opin. Biol. Ther., 2008, 8(3), 255-268.
[http://dx.doi.org/10.1517/14712598.8.3.255] [PMID: 18294098]

Wei, X.; Yang, X.; Han, Z.P.; Qu, F.F.; Shao, L.; Shi, Y.F. Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol. Sin., 2013, 34(6), 747-754.
[http://dx.doi.org/10.1038/aps.2013.50] [PMID: 23736003]

Siniscalco, D.; Giordano, C.; Galderisi, U.; Luongo, L.; Alessio, N.; Di Bernardo, G.; de Novellis, V.; Rossi, F.; Maione, S. Intra-brain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice. Cell. Mol. Life Sci., 2010, 67(4), 655-669.
[http://dx.doi.org/10.1007/s00018-009-0202-4] [PMID: 19937263]

Teixeira, F.G.; Carvalho, M.M.; Sousa, N.; Salgado, A.J. Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration? Cell. Mol. Life Sci., 2013, 70(20), 3871-3882.
[http://dx.doi.org/10.1007/s00018-013-1290-8] [PMID: 23456256]

Castorina, A.; Szychlinska, M.A.; Marzagalli, R.; Musumeci, G. Mesenchymal stem cells-based therapy as a potential treatment in neuro-degenerative disorders: is the escape from senescence an answer? Neural Regen. Res., 2015, 10(6), 850-858.
[http://dx.doi.org/10.4103/1673-5374.158352] [PMID: 26199588]

Li, Y.; Chen, J.; Chen, X.G.; Wang, L.; Gautam, S.C.; Xu, Y.X.; Katakowski, M.; Zhang, L.J.; Lu, M.; Janakiraman, N.; Chopp, M. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology, 2002, 59(4), 514-523.
[http://dx.doi.org/10.1212/WNL.59.4.514] [PMID: 12196642]

Lu, D.; Mahmood, A.; Chopp, M. Biologic transplantation and neurotrophin-induced neuroplasticity after traumatic brain injury. J. Head Trauma Rehabil., 2003, 18(4), 357-376.
[http://dx.doi.org/10.1097/00001199-200307000-00006] [PMID: 16222130]

Mahmood, A.; Lu, D.; Chopp, M. Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J. Neurotrauma, 2004, 21(1), 33-39.
[http://dx.doi.org/10.1089/089771504772695922] [PMID: 14987463]

Chen, X.; Katakowski, M.; Li, Y.; Lu, D.; Wang, L.; Zhang, L.; Chen, J.; Xu, Y.; Gautam, S.; Mahmood, A.; Chopp, M. Human bone mar-row stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production. J. Neurosci. Res., 2002, 69(5), 687-691.
[http://dx.doi.org/10.1002/jnr.10334] [PMID: 12210835]

Xin, H.; Li, Y.; Buller, B.; Katakowski, M.; Zhang, Y.; Wang, X.; Shang, X.; Zhang, Z.G.; Chopp, M. Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells, 2012, 30(7), 1556-1564.
[http://dx.doi.org/10.1002/stem.1129] [PMID: 22605481]

Xin, H.; Li, Y.; Cui, Y.; Yang, J.J.; Zhang, Z.G.; Chopp, M. Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J. Cereb. Blood Flow Metab., 2013, 33(11), 1711-1715.
[http://dx.doi.org/10.1038/jcbfm.2013.152] [PMID: 23963371]

Baek, G.; Choi, H.; Kim, Y.; Lee, H.C.; Choi, C. Mesenchymal Stem Cell-Derived Extracellular Vesicles as Therapeutics and as a Drug Delivery Platform. Stem Cells Transl. Med., 2019, 8(9), 880-886.
[http://dx.doi.org/10.1002/sctm.18-0226] [PMID: 31045328]

Vakhshiteh, F.; Atyabi, F.; Ostad, S.N. Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy. Int. J. Nanomedicine, 2019, 14, 2847-2859.
[http://dx.doi.org/10.2147/IJN.S200036] [PMID: 31114198]

Grange, C.; Tapparo, M.; Collino, F.; Vitillo, L.; Damasco, C.; Deregibus, M.C.; Tetta, C.; Bussolati, B.; Camussi, G. Microvesicles re-leased from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res., 2011, 71(15), 5346-5356.
[http://dx.doi.org/10.1158/0008-5472.CAN-11-0241] [PMID: 21670082]

Lee, H.K.; Finniss, S.; Cazacu, S.; Bucris, E.; Ziv-Av, A.; Xiang, C.; Bobbitt, K.; Rempel, S.A.; Hasselbach, L.; Mikkelsen, T.; Slavin, S.; Brodie, C. Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migra-tion and self-renewal. Oncotarget, 2013, 4(2), 346-361.
[http://dx.doi.org/10.18632/oncotarget.868] [PMID: 23548312]

The Safety and the Efficacy Evaluation of Allogenic Adipose MSC-Exos in Patients With Alzheimer's Disease. In: ClinicalTrials. gov;, 2020.

Therapeutic Potential of Stem Cell Conditioned Medium on Chronic Ulcer Wounds. In: ClinicalTrials.gov;, 2021.

microRNAs Role in Pre-eclampsia Diagnosis. In: ClinicalTrials. gov, 2021.

Exosome of Mesenchymal Stem Cells for Multiple Organ Dysfuntion Syndrome After Surgical Repaire of Acute Type A Aortic Dissection. In: ClinicalTrials.gov, 2021.

Klein, M.E.; Lioy, D.T.; Ma, L.; Impey, S.; Mandel, G.; Goodman, R.H. Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat. Neurosci., 2007, 10(12), 1513-1514.
[http://dx.doi.org/10.1038/nn2010] [PMID: 17994015]

Smith, P.Y.; Delay, C.; Girard, J.; Papon, M.A.; Planel, E.; Sergeant, N.; Buée, L.; Hébert, S.S. MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy. Hum. Mol. Genet., 2011, 20(20), 4016-4024.
[http://dx.doi.org/10.1093/hmg/ddr330] [PMID: 21807765]

An, F.; Gong, G.; Wang, Y.; Bian, M.; Yu, L.; Wei, C. MiR-124 acts as a target for Alzheimer’s disease by regulating BACE1. Oncotarget, 2017, 8(69), 114065-114071.
[http://dx.doi.org/10.18632/oncotarget.23119] [PMID: 29371969]

Hébert, S.S.; Horré, K.; Nicolaï, L.; Papadopoulou, A.S.; Mandemakers, W.; Silahtaroglu, A.N.; Kauppinen, S.; Delacourte, A.; De Stroop-er, B. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. USA, 2008, 105(17), 6415-6420.
[http://dx.doi.org/10.1073/pnas.0710263105] [PMID: 18434550]

Madadi, S.; Saidijam, M.; Yavari, B.; Soleimani, M. Downregulation of serum miR-106b: a potential biomarker for Alzheimer disease. Arch. Physiol. Biochem., 2020, 1-5.
[http://dx.doi.org/10.1080/13813455.2020.1734842] [PMID: 32141790]

Liu, C.G.; Wang, J.L.; Li, L.; Xue, L.X.; Zhang, Y.Q.; Wang, P.C. MicroRNA-135a and -200b, potential Biomarkers for Alzheimers disease, regulate β secretase and amyloid precursor protein. Brain Res., 2014, 1583, 55-64.
[http://dx.doi.org/10.1016/j.brainres.2014.04.026] [PMID: 25152461]

Yang, T.T.; Liu, C.G.; Gao, S.C.; Zhang, Y.; Wang, P.C. The Serum Exosome Derived MicroRNA-135a, -193b, and -384 Were Potential Alzheimer’s Disease Biomarkers. Biomed. Environ. Sci., 2018, 31(2), 87-96.
[PMID: 29606187]

Lukiw, W.J.; Alexandrov, P.N.; Zhao, Y.; Hill, J.M.; Bhattacharjee, S. Spreading of Alzheimer’s disease inflammatory signaling through soluble micro-RNA. Neuroreport, 2012, 23(10), 621-626.
[http://dx.doi.org/10.1097/WNR.0b013e32835542b0] [PMID: 22660168]

Sierksma, A.; Lu, A.; Salta, E.; Vanden Eynden, E.; Callaerts-Vegh, Z.; D’Hooge, R.; Blum, D.; Buée, L.; Fiers, M.; De Strooper, B. Dereg-ulation of neuronal miRNAs induced by amyloid-β or TAU pathology. Mol. Neurodegener., 2018, 13(1), 54.
[http://dx.doi.org/10.1186/s13024-018-0285-1] [PMID: 30314521]

Li, T.R.; Jia, Y.J.; Ma, C.; Qiu, W.Y.; Wang, Q.; Shao, X.Q.; Lv, R.J. The role of the microRNA-146a/complement factor H/interleukin-1β-mediated inflammatory loop circuit in the perpetuate inflammation of chronic temporal lobe epilepsy. Dis. Model. Mech., 2018, 11.
[http://dx.doi.org/10.1242/dmm.031708]

Long, J.M.; Ray, B.; Lahiri, D.K. MicroRNA-153 physiologically inhibits expression of amyloid-β precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients. J. Biol. Chem., 2012, 287(37), 31298-31310.
[http://dx.doi.org/10.1074/jbc.M112.366336] [PMID: 22733824]

Wang, H.; Li, X.; Li, T.; Wang, L.; Wu, X.; Liu, J.; Xu, Y.; Wei, W. Multiple roles of microRNA-146a in immune responses and hepatocel-lular carcinoma. Oncol. Lett., 2019, 18(5), 5033-5042.
[http://dx.doi.org/10.3892/ol.2019.10862] [PMID: 31612014]

Kou, X.; Chen, D.; Chen, N. The Regulation of microRNAs in Alzheimer’s Disease. Front. Neurol., 2020, 11, 288.
[http://dx.doi.org/10.3389/fneur.2020.00288] [PMID: 32362867]

Parsi, S.; Smith, P.Y.; Goupil, C.; Dorval, V.; Hébert, S.S. Preclinical Evaluation of miR-15/107 Family Members as Multifactorial Drug Targets for Alzheimer’s Disease. Mol. Ther. Nucleic Acids, 2015, 4, e256.
[http://dx.doi.org/10.1038/mtna.2015.33] [PMID: 26440600]

Hébert, S.S.; Horré, K.; Nicolaï, L.; Bergmans, B.; Papadopoulou, A.S.; Delacourte, A.; De Strooper, B. MicroRNA regulation of Alz-heimer’s Amyloid precursor protein expression. Neurobiol. Dis., 2009, 33(3), 422-428.
[http://dx.doi.org/10.1016/j.nbd.2008.11.009] [PMID: 19110058]

Delay, C.; Calon, F.; Mathews, P.; Hébert, S.S. Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function. Mol. Neurodegener., 2011, 6, 70.
[http://dx.doi.org/10.1186/1750-1326-6-70] [PMID: 21982160]

Tan, L.; Yu, J.T.; Liu, Q.Y.; Tan, M.S.; Zhang, W.; Hu, N.; Wang, Y.L.; Sun, L.; Jiang, T.; Tan, L. Circulating miR-125b as a biomarker of Alzheimer’s disease. J. Neurol. Sci., 2014, 336(1-2), 52-56.
[http://dx.doi.org/10.1016/j.jns.2013.10.002] [PMID: 24139697]

Geekiyanage, H.; Chan, C. MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid β novel targets in sporadic Alzheimer’s disease. J. Neurosci., 2011, 31(41), 14820-14830.
[http://dx.doi.org/10.1523/JNEUROSCI.3883-11.2011] [PMID: 21994399]

Boissonneault, V.; Plante, I.; Rivest, S.; Provost, P. MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid pre-cursor protein-converting enzyme 1. J. Biol. Chem., 2009, 284(4), 1971-1981.
[http://dx.doi.org/10.1074/jbc.M807530200] [PMID: 18986979]

O’Brien, R.J.; Wong, P.C. Amyloid precursor protein processing and Alzheimer’s disease. Annu. Rev. Neurosci., 2011, 34, 185-204.
[http://dx.doi.org/10.1146/annurev-neuro-061010-113613] [PMID: 21456963]

Wang, M.; Qin, L.; Tang, B. MicroRNAs in Alzheimer’s Disease. Front. Genet., 2019, 10, 153.
[http://dx.doi.org/10.3389/fgene.2019.00153] [PMID: 30881384]

Wang, X.; Liu, D.; Huang, H.Z.; Wang, Z.H.; Hou, T.Y.; Yang, X.; Pang, P.; Wei, N.; Zhou, Y.F.; Dupras, M.J.; Calon, F.; Wang, Y.T.; Man, H.Y.; Chen, J.G.; Wang, J.Z.; Hébert, S.S.; Lu, Y.; Zhu, L.Q. A Novel MicroRNA-124/PTPN1 Signal Pathway Mediates Synaptic and Memory Deficits in Alzheimer’s Disease. Biol. Psychiatry, 2018, 83(5), 395-405.
[http://dx.doi.org/10.1016/j.biopsych.2017.07.023] [PMID: 28965984]

Smirnova, L.; Gräfe, A.; Seiler, A.; Schumacher, S.; Nitsch, R.; Wulczyn, F.G. Regulation of miRNA expression during neural cell specifi-cation. Eur. J. Neurosci., 2005, 21(6), 1469-1477.
[http://dx.doi.org/10.1111/j.1460-9568.2005.03978.x] [PMID: 15845075]

Cao, J.; Huang, M.; Guo, L.; Zhu, L.; Hou, J.; Zhang, L.; Pero, A.; Ng, S.; El Gaamouch, F.; Elder, G.; Sano, M.; Goate, A.; Tcw, J.; Haroutunian, V.; Zhang, B.; Cai, D. MicroRNA-195 rescues ApoE4-induced cognitive deficits and lysosomal defects in Alzheimer’s dis-ease pathogenesis. Mol. Psychiatry, 2020.
[PMID: 32632205]

Kole, A.J.; Swahari, V.; Hammond, S.M.; Deshmukh, M. miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis. Genes Dev., 2011, 25(2), 125-130.
[http://dx.doi.org/10.1101/gad.1975411] [PMID: 21245165]

Sarkar, S.; Jun, S.; Rellick, S.; Quintana, D.D.; Cavendish, J.Z.; Simpkins, J.W. Expression of microRNA-34a in Alzheimer’s disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity. Brain Res., 2016, 1646, 139-151.
[http://dx.doi.org/10.1016/j.brainres.2016.05.026] [PMID: 27235866]

Higaki, S.; Muramatsu, M.; Matsuda, A.; Matsumoto, K.; Satoh, J.I.; Michikawa, M.; Niida, S. Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer’s disease models. PLoS One, 2018, 13(5), e0196929.
[http://dx.doi.org/10.1371/journal.pone.0196929] [PMID: 29738527]

Fu, J.; Peng, L.; Tao, T.; Chen, Y.; Li, Z.; Li, J. Regulatory roles of the miR-200 family in neurodegenerative diseases. Biomed. Pharmacother., 2019, 119, 109409.
[http://dx.doi.org/10.1016/j.biopha.2019.109409] [PMID: 31518873]

Wang, Z.H.; Zhang, J.L.; Duan, Y.L.; Zhang, Q.S.; Li, G.F.; Zheng, D.L. MicroRNA-214 participates in the neuroprotective effect of Resveratrol via inhibiting α-synuclein expression in MPTP-induced Parkinson’s disease mouse. Biomed. Pharmacother., 2015, 74, 252-256.
[http://dx.doi.org/10.1016/j.biopha.2015.08.025] [PMID: 26349993]

Recasens, A.; Perier, C.; Sue, C.M. Role of microRNAs in the Regulation of α-Synuclein Expression: A Systematic Review. Front. Mol. Neurosci., 2016, 9, 128.
[http://dx.doi.org/10.3389/fnmol.2016.00128] [PMID: 27917109]

Zhao, L.; Wang, Z. MicroRNAs: Game Changers in the Regulation of α-Synuclein in Parkinson’s Disease. Parkinsons Dis., 2019, 2019, 1743183.
[http://dx.doi.org/10.1155/2019/1743183] [PMID: 31191899]

Dong, H.; Wang, C.; Lu, S.; Yu, C.; Huang, L.; Feng, W.; Xu, H.; Chen, X.; Zen, K.; Yan, Q.; Liu, W.; Zhang, C.; Zhang, C.Y. A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson’s disease. Biomarkers, 2016, 21(2), 129-137.
[http://dx.doi.org/10.3109/1354750X.2015.1118544] [PMID: 26631297]

Tatura, R.; Kraus, T.; Giese, A.; Arzberger, T.; Buchholz, M.; Höglinger, G.; Müller, U. Parkinson’s disease: SNCA-, PARK2-, and LRRK2- targeting microRNAs elevated in cingulate gyrus. Parkinsonism Relat. Disord., 2016, 33, 115-121.
[http://dx.doi.org/10.1016/j.parkreldis.2016.09.028] [PMID: 27717584]

Prajapati, P.; Sripada, L.; Singh, K.; Bhatelia, K.; Singh, R.; Singh, R. TNF-α regulates miRNA targeting mitochondrial complex-I and in-duces cell death in dopaminergic cells. Biochim. Biophys. Acta, 2015, 1852(3), 451-461.
[http://dx.doi.org/10.1016/j.bbadis.2014.11.019] [PMID: 25481834]

Junn, E.; Lee, K.W.; Jeong, B.S.; Chan, T.W.; Im, J.Y.; Mouradian, M.M. Repression of alpha-synuclein expression and toxicity by mi-croRNA-7. Proc. Natl. Acad. Sci. USA, 2009, 106(31), 13052-13057.
[http://dx.doi.org/10.1073/pnas.0906277106] [PMID: 19628698]

Zhou, Y.; Lu, M.; Du, R.H.; Qiao, C.; Jiang, C.Y.; Zhang, K.Z.; Ding, J.H.; Hu, G. MicroRNA-7 targets Nod-like receptor protein 3 in-flammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease. Mol. Neurodegener., 2016, 11, 28.
[http://dx.doi.org/10.1186/s13024-016-0094-3] [PMID: 27084336]

Kabaria, S.; Choi, D.C.; Chaudhuri, A.D.; Jain, M.R.; Li, H.; Junn, E. MicroRNA-7 activates Nrf2 pathway by targeting Keap1 expression. Free Radic. Biol. Med., 2015, 89, 548-556.
[http://dx.doi.org/10.1016/j.freeradbiomed.2015.09.010] [PMID: 26453926]

Chaudhuri, A.D.; Choi, D.C.; Kabaria, S.; Tran, A.; Junn, E. MicroRNA-7 regulates the function of mitochondrial permeability transition pore by targeting VDAC1 expression. J. Biol. Chem., 2016, 291(12), 6483-6493.
[http://dx.doi.org/10.1074/jbc.M115.691352] [PMID: 26801612]

Doxakis, E. Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J. Biol. Chem., 2010, 285(17), 12726-12734.
[http://dx.doi.org/10.1074/jbc.M109.086827] [PMID: 20106983]

Decressac, M.; Mattsson, B.; Weikop, P.; Lundblad, M.; Jakobsson, J.; Björklund, A. TFEB-mediated autophagy rescues midbrain dopa-mine neurons from α-synuclein toxicity. Proc. Natl. Acad. Sci. USA, 2013, 110(19), E1817-E1826.
[http://dx.doi.org/10.1073/pnas.1305623110] [PMID: 23610405]

Xiong, R.; Wang, Z.; Zhao, Z.; Li, H.; Chen, W.; Zhang, B.; Wang, L.; Wu, L.; Li, W.; Ding, J.; Chen, S. MicroRNA-494 reduces DJ-1 ex-pression and exacerbates neurodegeneration. Neurobiol. Aging, 2014, 35(3), 705-714.
[http://dx.doi.org/10.1016/j.neurobiolaging.2013.09.027] [PMID: 24269020]

Cho, H.J.; Liu, G.; Jin, S.M.; Parisiadou, L.; Xie, C.; Yu, J.; Sun, L.; Ma, B.; Ding, J.; Vancraenenbroeck, R.; Lobbestael, E.; Baekelandt, V.; Taymans, J.M.; He, P.; Troncoso, J.C.; Shen, Y.; Cai, H. MicroRNA-205 regulates the expression of Parkinson’s disease-related leu-cine-rich repeat kinase 2 protein. Hum. Mol. Genet., 2013, 22(3), 608-620.
[http://dx.doi.org/10.1093/hmg/dds470] [PMID: 23125283]

Cardo, L.F.; Coto, E.; Ribacoba, R.; Mata, I.F.; Moris, G.; Menéndez, M.; Alvarez, V. The screening of the 3'UTR sequence of LRRK2 identified an association between the rs66737902 polymorphism and Parkinson’s disease. J. Hum. Genet., 2014, 59(6), 346-348.
[http://dx.doi.org/10.1038/jhg.2014.26] [PMID: 24758914]

Zhao, Y.; Bhattacharjee, S.; Jones, B.M.; Dua, P.; Alexandrov, P.N.; Hill, J.M.; Lukiw, W.J. Regulation of TREM2 expression by an NF-кB-sensitive miRNA-34a. Neuroreport, 2013, 24(6), 318-323.
[http://dx.doi.org/10.1097/WNR.0b013e32835fb6b0] [PMID: 23462268]

Zhao, Y.; Jaber, V.; Lukiw, W.J. Over-Expressed Pathogenic miRNAs in Alzheimer’s Disease (AD) and Prion Disease (PrD) Drive Defi-cits in TREM2-Mediated Aβ42 Peptide Clearance. Front. Aging Neurosci., 2016, 8, 140.
[http://dx.doi.org/10.3389/fnagi.2016.00140] [PMID: 27378912]

Thackray, A.M.; Lam, B.; Shahira, B. Ab Razak, A.; Yeo, G.; Bujdoso, R. Transcriptional signature of prion-induced neurotoxicity in a Drosophila model of transmissible mammalian prion disease. Biochem. J., 2020, 477(4), 833-852.
[http://dx.doi.org/10.1042/BCJ20190872] [PMID: 32108870]

Tai, M.C.; Kajino, T.; Nakatochi, M.; Arima, C.; Shimada, Y.; Suzuki, M.; Miyoshi, H.; Yatabe, Y.; Yanagisawa, K.; Takahashi, T. miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer. Carcinogenesis, 2015, 36(12), 1464-1473.
[http://dx.doi.org/10.1093/carcin/bgv152] [PMID: 26483346]

Cui, J.G.; Li, Y.Y.; Zhao, Y.; Bhattacharjee, S.; Lukiw, W.J. Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease. J. Biol. Chem., 2010, 285(50), 38951-38960.
[http://dx.doi.org/10.1074/jbc.M110.178848] [PMID: 20937840]

Alleaume-Butaux, A.; Nicot, S.; Pietri, M.; Baudry, A.; Dakowski, C.; Tixador, P.; Ardila-Osorio, H.; Haeberlé, A.M.; Bailly, Y.; Peyrin, J.M.; Launay, J.M.; Kellermann, O.; Schneider, B. Double-Edge Sword of Sustained ROCK Activation in Prion Diseases through Neurito-genesis Defects and Prion Accumulation. PLoS Pathog., 2015, 11(8), e1005073.
[http://dx.doi.org/10.1371/journal.ppat.1005073] [PMID: 26241960]

Feng, B.; Chakrabarti, S. miR-320 Regulates Glucose-Induced Gene Expression in Diabetes. ISRN Endocrinol., 2012, 2012, 549875.
[http://dx.doi.org/10.5402/2012/549875] [PMID: 22900199]

LaCasse, R.A.; Striebel, J.F.; Favara, C.; Kercher, L.; Chesebro, B. Role of Erk1/2 activation in prion disease pathogenesis: absence of CCR1 leads to increased Erk1/2 activation and accelerated disease progression. J. Neuroimmunol., 2008, 196(1-2), 16-26.
[http://dx.doi.org/10.1016/j.jneuroim.2008.02.009] [PMID: 18396336]

Caetano, F.A.; Lopes, M.H.; Hajj, G.N.; Machado, C.F.; Pinto Arantes, C.; Magalhães, A.C. Vieira, Mde.P.; Américo, T.A.; Massensini, A.R.; Priola, S.A.; Vorberg, I.; Gomez, M.V.; Linden, R.; Prado, V.F.; Martins, V.R.; Prado, M.A. Endocytosis of prion protein is required for ERK1/2 signaling induced by stress-inducible protein 1. J. Neurosci., 2008, 28(26), 6691-6702.
[http://dx.doi.org/10.1523/JNEUROSCI.1701-08.2008] [PMID: 18579743]

Relaño-Ginés, A.; Lehmann, S.; Crozet, C. Prion diseases and adult neurogenesis: how do prions counteract the brain’s endogenous repair machinery? Prion, 2014, 8(3), 240-246.
[http://dx.doi.org/10.4161/pri.29021] [PMID: 24831876]

Evangelisti, C.; Florian, M.C.; Massimi, I.; Dominici, C.; Giannini, G.; Galardi, S.; Buè, M.C.; Massalini, S.; McDowell, H.P.; Messi, E.; Gulino, A.; Farace, M.G.; Ciafrè, S.A. MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness. FASEB J., 2009, 23(12), 4276-4287.
[http://dx.doi.org/10.1096/fj.09-134965] [PMID: 19713529]

Han, N.; Zhao, W.; Zhang, Z.; Zheng, P. MiR-328 suppresses the survival of esophageal cancer cells by targeting PLCE1. Biochem. Biophys. Res. Commun., 2016, 470(1), 175-180.
[http://dx.doi.org/10.1016/j.bbrc.2016.01.020] [PMID: 26773497]

Fan, X.Y.; Tian, C.; Wang, H.; Xu, Y.; Ren, K.; Zhang, B.Y.; Gao, C.; Shi, Q.; Meng, G.; Zhang, L.B.; Zhao, Y.J.; Shao, Q.X.; Dong, X.P. Activation of the AMPK-ULK1 pathway plays an important role in autophagy during prion infection. Sci. Rep., 2015, 5, 14728.
[http://dx.doi.org/10.1038/srep14728] [PMID: 26423766]

Hao, Z.; Wang, G. Autophagy and Prion Disease. Adv. Exp. Med. Biol., 2020, 1207, 75-85.
[http://dx.doi.org/10.1007/978-981-15-4272-5_4] [PMID: 32671739]

Burak, K.; Lamoureux, L.; Boese, A.; Majer, A.; Saba, R.; Niu, Y.; Frost, K.; Booth, S.A. MicroRNA-16 targets mRNA involved in neurite extension and branching in hippocampal neurons during presymptomatic prion disease. Neurobiol. Dis., 2018, 112, 1-13.
[http://dx.doi.org/10.1016/j.nbd.2017.12.011] [PMID: 29277556]

Norsworthy, P.J.; Thompson, A.G.B.; Mok, T.H.; Guntoro, F.; Dabin, L.C.; Nihat, A.; Paterson, R.W.; Schott, J.M.; Collinge, J.; Mead, S.; Viré, E.A. A blood miRNA signature associates with sporadic Creutzfeldt-Jakob disease diagnosis. Nat. Commun., 2020, 11(1), 3960.
[http://dx.doi.org/10.1038/s41467-020-17655-x] [PMID: 32769986]

Yang, Y.T.; Jin, S. Effect of PrP105-132 on the secretion of interleukin-6 and interleukin-8 from microglial cells in vitro. Exp. Ther. Med., 2018, 15(1), 999-1004.
[PMID: 29399107]

Fabbri, E.; Montagner, G.; Bianchi, N.; Finotti, A.; Borgatti, M.; Lampronti, I.; Cabrini, G.; Gambari, R. MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells. Oncol. Rep., 2016, 35(5), 2866-2872.
[http://dx.doi.org/10.3892/or.2016.4676] [PMID: 26986724]

Xiong, J.; Yu, D.; Wei, N.; Fu, H.; Cai, T.; Huang, Y.; Wu, C.; Zheng, X.; Du, Q.; Lin, D.; Liang, Z. An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples. FEBS J., 2010, 277(7), 1684-1694.
[http://dx.doi.org/10.1111/j.1742-4658.2010.07594.x] [PMID: 20180843]

Jovicic, A.; Zaldivar, J.J.F.; Moser, R.; Silva, S. Mde.F.; Luthi-Carter, R. MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington’s disease-related mechanisms. PLoS One, 2013, 8(1), e54222.
[http://dx.doi.org/10.1371/journal.pone.0054222] [PMID: 23349832]

Chen, D.; Hu, S.; Wu, Z.; Liu, J.; Li, S. The Role of MiR-132 in regulating neural stem cell proliferation, differentiation and neuronal matu-ration. Cell. Physiol. Biochem., 2018, 47(6), 2319-2330.
[http://dx.doi.org/10.1159/000491543] [PMID: 29982261]

Makeyev, E.V.; Zhang, J.; Carrasco, M.A.; Maniatis, T. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol. Cell, 2007, 27(3), 435-448.
[http://dx.doi.org/10.1016/j.molcel.2007.07.015] [PMID: 17679093]

Liu, T. Im, W.; Mook-Jung, I.; Kim, M. MicroRNA-124 slows down the progression of Huntington’s disease by promoting neurogenesis in the striatum. Neural Regen. Res., 2015, 10(5), 786-791.
[http://dx.doi.org/10.4103/1673-5374.156978] [PMID: 26109954]

Moumné, L.; Betuing, S.; Caboche, J. Multiple Aspects of Gene Dysregulation in Huntington’s Disease. Front. Neurol., 2013, 4, 127.
[http://dx.doi.org/10.3389/fneur.2013.00127] [PMID: 24167500]

Tan, L.; Yu, J.T.; Tan, L. Causes and consequences of MicroRNA dysregulation in neurodegenerative diseases. Mol. Neurobiol., 2015, 51(3), 1249-1262.
[http://dx.doi.org/10.1007/s12035-014-8803-9] [PMID: 24973986]

Kunkanjanawan, T.; Carter, R.L.; Prucha, M.S.; Yang, J.; Parnpai, R.; Chan, A.W. miR-196a ameliorates cytotoxicity and cellular pheno-type in transgenic Huntington’s disease monkey neural cells. PLoS One, 2016, 11(9), e0162788.
[http://dx.doi.org/10.1371/journal.pone.0162788] [PMID: 27631085]

Hoss, A.G.; Labadorf, A.; Latourelle, J.C.; Kartha, V.K.; Hadzi, T.C.; Gusella, J.F.; MacDonald, M.E.; Chen, J.F.; Akbarian, S.; Weng, Z.; Vonsattel, J.P.; Myers, R.H. miR-10b-5p expression in Huntington’s disease brain relates to age of onset and the extent of striatal in-volvement. BMC Med. Genomics, 2015, 8, 10.
[http://dx.doi.org/10.1186/s12920-015-0083-3] [PMID: 25889241]

Hoss, A.G.; Lagomarsino, V.N.; Frank, S.; Hadzi, T.C.; Myers, R.H.; Latourelle, J.C. Study of plasma-derived miRNAs mimic differences in Huntington’s disease brain. Mov. Disord., 2015, 30(14), 1961-1964.
[http://dx.doi.org/10.1002/mds.26457] [PMID: 26573701]

Jamwal, S.; Kumar, P. Antidepressants for neuroprotection in Huntington’s disease: A review. Eur. J. Pharmacol., 2015, 769, 33-42.
[http://dx.doi.org/10.1016/j.ejphar.2015.10.033] [PMID: 26511378]

Lewis, B.P.; Burge, C.B.; Bartel, D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 2005, 120(1), 15-20.
[http://dx.doi.org/10.1016/j.cell.2004.12.035] [PMID: 15652477]

Sonkoly, E.; Ståhle, M.; Pivarcsi, A. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflamma-tion. Semin. Cancer Biol., 2008, 18(2), 131-140.
[http://dx.doi.org/10.1016/j.semcancer.2008.01.005] [PMID: 18291670]

Sinha, M.; Ghose, J.; Das, E.; Bhattarcharyya, N.P. Altered microRNAs in STHdh(Q111)/Hdh(Q111) cells: miR-146a targets TBP. Biochem. Biophys. Res. Commun., 2010, 396(3), 742-747.
[http://dx.doi.org/10.1016/j.bbrc.2010.05.007] [PMID: 20451497]

Laprairie, R.B.; Petr, G.T.; Sun, Y.; Fischer, K.D.; Denovan-Wright, E.M.; Rosenberg, P.A. Huntington’s disease pattern of transcriptional dysregulation in the absence of mutant huntingtin is produced by knockout of neuronal GLT-1. Neurochem. Int., 2019, 123, 85-94.
[http://dx.doi.org/10.1016/j.neuint.2018.04.015] [PMID: 29709465]

Sinha, M.; Ghose, J.; Bhattarcharyya, N.P. Micro RNA -214,-150,-146a and-125b target Huntingtin gene. RNA Biol., 2011, 8(6), 1005-1021.
[http://dx.doi.org/10.4161/rna.8.6.16035] [PMID: 22048026]

Kozlowska, E.; Krzyzosiak, W.J.; Koscianska, E. Regulation of huntingtin gene expression by miRNA-137, -214, -148a, and their respec-tive isomiRs. Int. J. Mol. Sci., 2013, 14(8), 16999-17016.
[http://dx.doi.org/10.3390/ijms140816999] [PMID: 23965969]

Chang, K.H.; Wu, Y.R.; Chen, C.M. Down-regulation of miR-9* in the peripheral leukocytes of Huntington’s disease patients. Orphanet J. Rare Dis., 2017, 12(1), 185.
[http://dx.doi.org/10.1186/s13023-017-0742-x] [PMID: 29258536]

Freischmidt, A.; Müller, K.; Ludolph, A.C.; Weishaupt, J.H. Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis. Acta Neuropathol. Commun., 2013, 1, 42.
[http://dx.doi.org/10.1186/2051-5960-1-42] [PMID: 24252274]

Taguchi, Y.H.; Wang, H. Exploring microRNA Biomarker for Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci., 2018, 19(5), 19.
[http://dx.doi.org/10.3390/ijms19051318] [PMID: 29710810]

Kovanda, A.; Leonardis, L.; Zidar, J.; Koritnik, B.; Dolenc-Groselj, L.; Ristic Kovacic, S.; Curk, T.; Rogelj, B. Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls. Sci. Rep., 2018, 8(1), 5609.
[http://dx.doi.org/10.1038/s41598-018-23139-2] [PMID: 29618798]

Vistbakka, J.; Elovaara, I.; Lehtimäki, T.; Hagman, S. Circulating microRNAs as biomarkers in progressive multiple sclerosis. Mult. Scler., 2017, 23(3), 403-412.
[http://dx.doi.org/10.1177/1352458516651141] [PMID: 27246141]

D’Erchia, A.M.; Gallo, A.; Manzari, C.; Raho, S.; Horner, D.S.; Chiara, M.; Valletti, A.; Aiello, I.; Mastropasqua, F.; Ciaccia, L.; Locatelli, F.; Pisani, F.; Nicchia, G.P.; Svelto, M.; Pesole, G.; Picardi, E. Massive transcriptome sequencing of human spinal cord tissues provides new insights into motor neuron degeneration in ALS. Sci. Rep., 2017, 7(1), 10046.
[http://dx.doi.org/10.1038/s41598-017-10488-7] [PMID: 28855684]

Recabarren-Leiva, D.; Alarcón, M. New insights into the gene expression associated to amyotrophic lateral sclerosis. Life Sci., 2018, 193, 110-123.
[http://dx.doi.org/10.1016/j.lfs.2017.12.016] [PMID: 29241710]

Liguori, M.; Nuzziello, N.; Introna, A.; Consiglio, A.; Licciulli, F.; D’Errico, E.; Scarafino, A.; Distaso, E.; Simone, I.L. Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci., 2018, 11, 288.
[http://dx.doi.org/10.3389/fnmol.2018.00288] [PMID: 30210287]

Liguori, M.; Nuzziello, N.; Licciulli, F.; Consiglio, A.; Simone, M.; Viterbo, R.G.; Creanza, T.M.; Ancona, N.; Tortorella, C.; Margari, L.; Grillo, G.; Giordano, P.; Liuni, S.; Trojano, M. Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an in-tegrated approach to uncover novel pathogenic mechanisms of the disease. Hum. Mol. Genet., 2018, 27(1), 66-79.
[http://dx.doi.org/10.1093/hmg/ddx385] [PMID: 29087462]

Satoh, J.; Kino, Y.; Niida, S. MicroRNA-seq data analysis pipeline to identify blood biomarkers for Alzheimer’s disease from public data. Biomark. Insights, 2015, 10, 21-31.
[http://dx.doi.org/10.4137/BMI.S25132] [PMID: 25922570]

Di Pietro, L.; Lattanzi, W.; Bernardini, C. Skeletal Muscle MicroRNAs as Key Players in the Pathogenesis of Amyotrophic Lateral Sclero-sis. Int. J. Mol. Sci., 2018, 19(5), 19.
[http://dx.doi.org/10.3390/ijms19051534] [PMID: 29786645]

Ebrahimkhani, S.; Vafaee, F.; Young, P.E.; Hur, S.S.J.; Hawke, S.; Devenney, E.; Beadnall, H.; Barnett, M.H.; Suter, C.M.; Buckland, M.E. Exosomal microRNA signatures in multiple sclerosis reflect disease status. Sci. Rep., 2017, 7(1), 14293.
[http://dx.doi.org/10.1038/s41598-017-14301-3] [PMID: 29084979]

Chang, W.S.; Wang, Y.H.; Zhu, X.T.; Wu, C.J. Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer’s Disease. Med. Sci. Monit., 2017, 23, 2721-2731.
[http://dx.doi.org/10.12659/MSM.905064] [PMID: 28578378]

Si, Y.; Cui, X.; Crossman, D.K.; Hao, J.; Kazamel, M.; Kwon, Y.; King, P.H. Muscle microRNA signatures as biomarkers of disease pro-gression in amyotrophic lateral sclerosis. Neurobiol. Dis., 2018, 114, 85-94.
[http://dx.doi.org/10.1016/j.nbd.2018.02.009] [PMID: 29486297]

Raheja, R.; Regev, K.; Healy, B.C.; Mazzola, M.A.; Beynon, V.; Von Glehn, F.; Paul, A.; Diaz-Cruz, C.; Gholipour, T.; Glanz, B.I.; Kivi-sakk, P.; Chitnis, T.; Weiner, H.L.; Berry, J.D.; Gandhi, R. Correlating serum micrornas and clinical parameters in amyotrophic lateral scle-rosis. Muscle Nerve, 2018, 58(2), 261-269.
[http://dx.doi.org/10.1002/mus.26106] [PMID: 29466830]

Devier, D.J.; Lovera, J.F.; Lukiw, W.J. Increase in NF-κB-sensitive miRNA-146a and miRNA-155 in multiple sclerosis (MS) and pro-inflammatory neurodegeneration. Front. Mol. Neurosci., 2015, 8, 5.
[http://dx.doi.org/10.3389/fnmol.2015.00005] [PMID: 25784854]

Wu, T.; Chen, G. miRNAs Participate in MS Pathological Processes and Its Therapeutic Response. Mediators Inflamm., 2016, 2016, 4578230.
[http://dx.doi.org/10.1155/2016/4578230] [PMID: 27073296]

Tufekci, K.U.; Oner, M.G.; Genc, S.; Genc, K. MicroRNAs and multiple sclerosis. Autoimmune Dis., 2010, 2011, 807426.
[PMID: 21188194]

Hu, Z.; Cui, Y.; Qiao, X.; He, X.; Li, F.; Luo, C.; Wang, S.; Li, C.; Dai, R. Silencing miR-150 ameliorates experimental autoimmune en-cephalomyelitis. Front. Neurosci., 2018, 12, 465.
[http://dx.doi.org/10.3389/fnins.2018.00465] [PMID: 30050402]

Noorbakhsh, F.; Ellestad, K.K.; Maingat, F.; Warren, K.G.; Han, M.H.; Steinman, L.; Baker, G.B.; Power, C. Impaired neurosteroid syn-thesis in multiple sclerosis. Brain, 2011, 134(Pt 9), 2703-2721.
[http://dx.doi.org/10.1093/brain/awr200] [PMID: 21908875]

Dolati, S.; Marofi, F.; Babaloo, Z.; Aghebati-Maleki, L.; Roshangar, L.; Ahmadi, M.; Rikhtegar, R.; Yousefi, M. Dysregulated network of miRNAs involved in the pathogenesis of multiple sclerosis. Biomed. Pharmacother., 2018, 104, 280-290.
[http://dx.doi.org/10.1016/j.biopha.2018.05.050] [PMID: 29775896]

Groen, K.; Maltby, V.E.; Lea, R.A.; Sanders, K.A.; Fink, J.L.; Scott, R.J.; Tajouri, L.; Lechner-Scott, J. Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis. BMC Med. Genomics, 2018, 11(1), 48.
[http://dx.doi.org/10.1186/s12920-018-0365-7] [PMID: 29783973]

Witte, M.E.; Nijland, P.G.; Drexhage, J.A.; Gerritsen, W.; Geerts, D.; van Het Hof, B.; Reijerkerk, A.; de Vries, H.E.; van der Valk, P.; van Horssen, J. Reduced expression of PGC-1α partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex. Acta Neuropathol., 2013, 125(2), 231-243.
[http://dx.doi.org/10.1007/s00401-012-1052-y] [PMID: 23073717]

Zhang, Q.; Ma, X.F.; Dong, M.Z.; Tan, J.; Zhang, J.; Zhuang, L.K.; Liu, S.S.; Xin, Y.N. MiR-30b-5p regulates the lipid metabolism by targeting PPARGC1A in Huh-7 cell line. Lipids Health Dis., 2020, 19(1), 76.
[http://dx.doi.org/10.1186/s12944-020-01261-3] [PMID: 32299444]

Tavakolpour, V.; Shokri, G.; Naser Moghadasi, A.; Mozafari Nahavandi, P.; Hashemi, M.; Kouhkan, F. Increased expression of mir-301a in PBMCs of patients with relapsing-remitting multiple sclerosis is associated with reduced NKRF and PIAS3 expression levels and dis-ease activity. J. Neuroimmunol., 2018, 325, 79-86.
[http://dx.doi.org/10.1016/j.jneuroim.2018.10.002] [PMID: 30316680]

Ma, X.; Zhou, J.; Zhong, Y.; Jiang, L.; Mu, P.; Li, Y.; Singh, N.; Nagarkatti, M.; Nagarkatti, P. Expression, regulation and function of mi-croRNAs in multiple sclerosis. Int. J. Med. Sci., 2014, 11(8), 810-818.
[http://dx.doi.org/10.7150/ijms.8647] [PMID: 24936144]

Fenoglio, C.; Ridolfi, E.; Cantoni, C.; De Riz, M.; Bonsi, R.; Serpente, M.; Villa, C.; Pietroboni, A.M.; Naismith, R.T.; Alvarez, E.; Parks, B.J.; Bresolin, N.; Cross, A.H.; Piccio, L.M.; Galimberti, D.; Scarpini, E. Decreased circulating miRNA levels in patients with primary pro-gressive multiple sclerosis. Mult. Scler., 2013, 19(14), 1938-1942.
[http://dx.doi.org/10.1177/1352458513485654] [PMID: 24277735]

Junker, A.; Krumbholz, M.; Eisele, S.; Mohan, H.; Augstein, F.; Bittner, R.; Lassmann, H.; Wekerle, H.; Hohlfeld, R.; Meinl, E. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain, 2009, 132(Pt 12), 3342-3352.
[http://dx.doi.org/10.1093/brain/awp300] [PMID: 19952055]

Mycko, M.P.; Cichalewska, M.; Cwiklinska, H.; Selmaj, K.W. miR-155-3p Drives the Development of Autoimmune Demyelination by Regulation of Heat Shock Protein 40. J. Neurosci., 2015, 35(50), 16504-16515.
[http://dx.doi.org/10.1523/JNEUROSCI.2830-15.2015] [PMID: 26674874]

Liu, S.Q.; Jiang, S.; Li, C.; Zhang, B.; Li, Q.J. miR-17-92 cluster targets phosphatase and tensin homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation. J. Biol. Chem., 2014, 289(18), 12446-12456.
[http://dx.doi.org/10.1074/jbc.M114.550723] [PMID: 24644282]

Ichiyama, K.; Gonzalez-Martin, A.; Kim, B.S.; Jin, H.Y.; Jin, W.; Xu, W.; Sabouri-Ghomi, M.; Xu, S.; Zheng, P.; Xiao, C.; Dong, C. The MicroRNA-183-96-182 Cluster Promotes T Helper 17 Cell Pathogenicity by Negatively Regulating Transcription Factor Foxo1 Expres-sion. Immunity, 2016, 44(6), 1284-1298.
[http://dx.doi.org/10.1016/j.immuni.2016.05.015] [PMID: 27332731]

Nuzziello, N.; Vilardo, L.; Pelucchi, P.; Consiglio, A.; Liuni, S.; Trojano, M.; Liguori, M. Investigating the Role of MicroRNA and Tran-scription Factor Co-regulatory Networks in Multiple Sclerosis Pathogenesis. Int. J. Mol. Sci., 2018, 19(11), 19.
[http://dx.doi.org/10.3390/ijms19113652] [PMID: 30463275]

Cardiac Changes in Early Parkinson's Disease: A Follow up Study. In: ClinicalTrials.gov, 2020.

Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease (SAVE-DH). In: Clinical- Trials.gov, 2020.

CJD (Creutzfeldt-Jakob Disease) Quinacrine Study. In: Clinical- Trials.gov, 2020.

Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS) (hNSCALS). In: ClinicalTrials.gov, 2020.

Neural Stem Cell Transplantation in Multiple Sclerosis Patients (STEMS). In: ClinicalTrials.gov, 2020.